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The misuse of antibiotics for viral infections (for which they are of no value) and the 
immoderate use of broad spectrum antibiotics instead of narrower spectrum antibiotics 
have been well-documented and reported. Therefore the inappropriate use of antibiotics is 
getting a global problem, mainly in the developing countries [1, 2].  Many factors have 
contributed to this problem such as improper drug selection, inappropriate dosage (over- 
use and under-use), patient non-compliance and practitioner type and specialty [3, 4, 5]. 
Despite the abundance of safe, effective and low-cost antibiotics since mid 20thcentury, 
resistance  to  existing  antibiotics  has  recently  become  widespread  and  created  a  great 
challenge to public health in the 21stcentury  [6, 7]. Previously, antibiotics resistance was 
thought to be an isolated hospitals problem due to nosocomial infections, long stay of 
patients and nursing homes. However, recently the proportion of community‐acquired 
(CA) infections with bacteria resistant to antibiotics has increased [8, 9].   Emergence of 
antibiotics resistance is often a result of irrational prescribing patterns, misuse of the 
antibiotics as well as self-medication. 
Recognition of the severity of antibiotics resistance in both developed and developing 
countries by medical, public health, scientific leaders and health organization worldwide 
leads them to developed national and regional surveillance systems to track the spread of 
hospital‐ and   CA   antibiotic   resistance,   raise   problem   awareness   and   stimulate 
governments to take action through policy interventions (Mossialos et al ., 2008)[10]. For 
instance, in 2006 the European Antimicrobial Resistance Surveillance System (EARSS) 
reported that pathogens resistant to penicillin occurred in up to 25.0‐50.0 % of isolates in 
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France, Spain, and Romania, 24.0%, 25.0%.88.0%; respectively [10, 11]. The United States 
of  America  (USA)  Centers  for  Disease  Control  and  Prevention  (CDC)  declared  that
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Although the United Arab Emirates (UAE]) antimicrobial policy restricts dispensing of 
antibiotics without prescription [13], studies revealed the wide availability of these agents 
over the counter (OTC), their over prescribing pattern and the high prevalence of self- 
medication with antibiotics [14, 15] unfortunately and regardless of this results, there is a lack 
and paucity in studies that tracking the prevalence of antibiotics resistance [16, 17]. 
World Health Organization (WHO) confesses that antimicrobial resistance is not just a 
country-level challenging problem, but it is a global and international issue. [18]. During the 
last decades the UAE has become the focus of researchers attention where we find that 
there is a tremendous increase in the volume of trade, travel and immigration, which led to 
a change in the population structure in terms of ethnic diversity and therefore social and 
cultural changes and these certainly will be a key factors in the spread and increase of the 
resistance of pathogenic bacteria.. 
To minimize the susceptible rates of resistance and for better evaluation of the benefits and 
risks of antibiotics, it‘s not suffice to assess only the patient‘s attitude (self-medication 
with antibiotics) and the prescribing patterns ,but it‘s very important to consider the well- 
established,  but  complex  relationship  between  the  consumption  and  utilization  of 
antibiotics and the prevalence of the resistance to them. 
Sequence of studies in this research shed light on this problem. This was especially in 
studies of the consumption and drug utilization and rational use of medicine and as well 






Self-medication and over the counter use of antibiotics is believed to be highly associated 
  
with the emergence of antibiotic resistance. For this reason and since this practice has a 
 
long history the in UAE, series of pharmaco-epidemiological studies were carried-out to 
evaluate the use of antibiotics in terms of self-medication, prescribing and dispensing 
patterns  in  UAE.  The  research  results  will  serve  as  platform  for  strict  and  solid 
interventions  for  better  use  of  antibiotics.  The following were the objectives of the 
research: 
 
 To evaluate the attitude of certain cohort (banking employees) of the community 
towards use of antibiotic (Study I). 
 




 To identify Abu Dhabi community socio-demographic factors related to self- 
medication with antibiotics (study II). 
 
 To Identify types of Antibiotics used for self-medication. (study II). 
 
 
  To characterize the sources of obtaining antibiotics without prescriptions and the 
reasons for their use (study II). 
 To realize the relationship between intended self-medication, storage, and actual self 
medication (study II). 
 
  To examine the impact of demographic charateristics (age,gender and  years of 
work experience) of the pharmacist with respect to dispensing antibiotics (with and/or 
without prescription) in terms of legalization, rationality and safety (Study III).
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  To study the pattern of dispensing antibiotics (with and/or without prescription) 














































3.1 Location and population 
 
 
United Arab Emirates (UAE) is located in the Middle East region of Asia. It is at the tip of 
the Arabian Peninsula, having borders with Saudi Arabia and Oman and is one of the GCC 
(Gulf Co-operation Council) States, and is comprises of seven emirates. The UAE seven 
emirates federation was officially announced on 2nd December 1971. The estimated 
population is 8,264,070 million people [20]  (Table1), comprised of different ethnic groups 
(88.5 % are expatriates) [21]. The Nominal gross domestic product (GDP) in 2011 was 360 
billion $ and the product gross national product per capita (GNP) is $ 41,550 [22]. 
 










Emirate Male Female Total 
Abu Dhabi 204,108 200,438 404,546 
Dubai 84,245 83,784 168,029 
Sharjah 78,818 74,547 153,365 
Ajman 21,600 20,586 42,186 
Umm Al-Quwain 8,671 8,811 17,482 
Ras Al Khaimah 49,181 48,348 97,529 
Fujairah 32,486 32,374 64,860 
Total 479,109 467,888 947,997 
 
 
Table 1-B      Population by Nationality (National-Non National) and sex (2010 midyear 
estimates) 
 
Nationality Male Female Total 
National 479,109 468,888 947,997 
Non-National 5,682,711 1,633,362 7,316,073 
Total 6,161,820 2,102,250 8,264,070 
 
 
** The table is cited from: National Bureau of Statistics 
 





3.2 The UAE Healthcare System 
 
 
In the early seventies, there were only 7 hospitals and 12 primary healthcare centers 
(PHCs) within the UAE, which reflect the limitations of healthcare facilities throughout the 
country. [23]  In 2000, The World Health Organization (WHO) ranked the UAE healthcare 
system 27th  best out of 191 countries, [24]. The standards of health care in the UAE are 
generally high, reflecting the high level of public spending over the decades since the oil 
boom. The provision of best healthcare has been reflected in rapidly improving figures for 
key indicators such as life expectancy and infant mortality rates [25]  (Table 2), which are 
now  considered  equivalent  to  western  levels  [26]     The latest  released  statistics  by the 
National Bureau of Statistics (UAE) indicated the following: 




    There were 65 private hospitals and 2927 clinics and centers in 2011. [27] (Table 4) 
 
 
The enormous expansion in healthcare infrastructure created an extra management burden 
on the MOH authorities and hence necessitated the development of a new healthcare 
management system in the country that resulted in the partnership between the federal 
government and each emirate local authorities.
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** The table is cited from: 













Item 20121 20111 2010 2009 2008 2007 
Hospitals 33 34 33 33 32 34 
Beds 7,125 7,929 7,035 7,061 6,627 7,607 
Clinics & Centres ××× 269 271 277 243 197 
Physicians 5,251 5,031 5,312 5,159 5,969 4,711 
Dentists 625 549 659 610 526 566 





××× Data not Available 
 
1- A D N O C  Data for the years 2011 & 2012 were calculated within the Private 
Sector. 
 
** The table is cited from: National Bureau of Statistics 
 












Item 20121 20111 2010 2009 2008 2007 
Hospitals 65 58 53 59 58 51 
Beds 3,494 2,556 2,557 2,665 2,549 2,076 
Clinics & Centers ... 2,927 2,394 2,087 2,057 2,135 
Physicians 11,166 7,866 7,440 6,847 7,342 5,412 
Dentists 3,557 2,126 2,257 2,408 2,412 1,879 
Nurses 15,736 10,611 9,473 7,948 8,688 3,876 
 
... Not Available 
 





** The table is cited from: National Bureau of Statistics 
 
 


















3.2.1 Federal Healthcare Management 
 
The Ministry of Health (MOH) manages government-run hospitals and PHCs, including 
their private counterparts, in all emirates except Abu Dhabi and Dubai emirates, where 




3.2.2 Local Healthcare Management 
 
This system of management is applied in the emirates of Abu Dhabi and Dubai. Dubai 
emirate has established its Department of Health and Medical Services (DOHMS), which 
recently has been renamed as Dubai Health Authority (DHA). In 2001[28], the Emirate of 
Abu Dhabi announced the formation of its local healthcare authority (General Authority 
for Health Services for the Emirate of Abu Dhabi (GAHS). In 2007 GAHS has been 
restructured into two organizations, the Abu Dhabi Health Authority (HAAD) and Abu 




3.2.3 Private Health care System 
 
3.2.3.1 Dubai Healthcare City 
 
The Government of Dubai has developed Dubai Healthcare City (DHCC), with the goal of 
creating a regional centre of excellence for medical services, medical education, and life 
sciences research in the Middle East. DHCC has international links with highly reputed 
global educational and research institutions. 
DHCC is to become the internationally recognized location of choice for quality healthcare 
and an integrated centre of excellence for clinical and wellness services, medical education 
and research. The Medical Community is also home to the Mohamed Bin Rashid Al 
Maktoum Academic Medical Centre with the integration of its entities, many of which 
have USA origins: the Harvard Medical School Dubai Centre (HMSDC) Institute for 
Postgraduate Education and Medical research; the University Teaching Hospital (UH); the 
Dubai Harvard Foundation for Medical research (DHFMR); Boston University Institute for 




3.3 Health Insurance 
 
Until May 2003, all resident regardless of their nationality were entitled to comprehensive 
free healthcare services. However, these services have been suspended due to financial 
considerations. Since then, non-GCC (Gulf Countries Citizens) nationals have had to pay a 
pre-determined sum for each provided service. 
In September 2005, GAHS launched a local health insurance scheme and it became 
mandatory, which obligated all the employers and business owners in the emirate of Abu 
Dhabi to cover the cost health care insurance for their expatriate employees and their 
families. A national health insurance company has been established for this purpose, which
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was named (Daman) [30] this venture embodied a signpost in the history of healthcare for 
the Emirate of Abu Dhabi. 
Three years later, in the middle of year 2008 a new health insurance program ―Thiqa‖ (or 
―trust‖) has been announced. Thiqa program was designed to provide    UAE nationals a 
wide-range of healthcare services at all public and private healthcare facilities.   Since 
national statistics shows high prevalence of hypertension and diabetes in UAE (diabetes 
estimated by 19 % these indicators led to ―Weqaya‖ (or ―protection‖) program offered by, 
HAAD and SEHA [31]  to predict risk factors for developing hypertension, diabetes and 
hypercholesterolaemia through free Weqaya health checks performed every two years. 
Cost of health services listed within the Daman scheme for the UAE nationals, is covered 
by Abu Dhabi government, while Non-UAE nationals can approach public hospitals and 
clinics of SEHA in the Abu Dhabi Emirate through their Daman and other insurance 
companies health cards [30] MOH established a new department for health insurance with 
responsibility to regulate and implements the health insurance system throughout the 
country.  A drafted UAE Federal law on health insurance has been submitted to the UAE 
Ministers‘ Cabinet for further discussion and approval. 
Dubai Emirate started implementation of the health insurance program in February 2014. 
 
3.4 Pharmaceutical sector in the UAE 
 
Pharmacy sector in the UAE is rapidly progressing. There are definite strengths in UAE 
pharmacy system for example; the pharmaceutical industry and pharmacy practice has 
been included in the UAE Federal Law since the early 1980s. The principal legislation that 
regulates pharmaceuticals and pharmacy practice in the country is the UAE Federal Law 
number  4  of  1983  for  Pharmaceutical  Professions  and  Institutions  .This  law  is  not 
obviously identifying the tasks and responsibilities of pharmacist; but article 16 has stated 
some guidance for the pharmacist‘s profession.
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Synopsis of “Law 4/1983/ Article 16 
 
The licensed pharmacist should carry out his duties in conformity with regulations of the 
profession and in particular: 
    Shall not conduct any practices against the honor of the profession. 
 
  Shall keep confidential the disease, which he may come to know through the 
medical prescription presented to him or through any means related to his 
practicing of his work. 
    Shall abide by the laws and regulations followed in this profession. 
 
 Shall notify the communicable diseases he may discover during practicing his 
duties. 





Although the numbers of pharmacists in the UAE are increasing, there is yet a shortage of 
pharmacists required to fulfill retail, hospital, industry, government and teaching positions 
in the country. (Table 5)
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520 29.99% 1305 29.70% 426 25.32% 
Dubai 560 32.30% 1572 36.90% 619 36.81% 
Sharjah 382 22.03% 708 19.40% 375 22.29% 
Ajman 120 6.92% 225 5.80% 116 6.90% 
Umm Al 
Qiween 
18 1.04% 41 1.00% 12 0.71% 
Fujairah 47 2.70% 87 1.80% 53 3.15% 
Ras Al 
Khaimah 
87 5.02% 167 5.40% 81 4.82% 








3.4.1 Dispensing Mode of Medicines 
 
 
In 2011 a ministerial decree No. MoH 922/2011 released and base on that, MOH re- 
classified and revised dispensing mode for the medicinal products in UAE therefore as per 
this new revision all drugs are now classified to the under one of the following categories 
(32) 
 
3.4.1.1 Controlled Drugs- Narcotics: 
 
This group included medicines, which are controlled according to the regulation of 
the International Narcotic Control Bureau (INCB). Dispensation /supply is only in 
hospitals, through Narcotic Medical Prescription Form. This is valid for 28 days 
and must be issued by a consultant physician e.g. Amphetamines and other 
stimulants (such as methylphenidate), opioids (such as morphine and oxycodone) 
and others 
3.4.1.1.1 Controlled Drugs- Class A (CD- A): 
 
The dispensation of these medicines only upon‖ Special Control‖ white medical 
 
prescription, which is valid only for 3 days e.g.benzodiazepines, 
 
3.4.1.1.2 Controlled Drugs- Class B (CD-B): 
 
The dispensation of these medicines only upon‖ Special Control‖ white medical 
prescription, which is valid only for 3 days e.g. anti- depressants, anti-convulsants. 
3.4.1.2 Medicines by prescriptions only (POM):- 
 
These medicinal products must be dispensed by a licensed pharmacist (in 




3.4.1.3 Medicines Restricted to pharmacist only (PH-OM):- 
 
These medicinal products must be dispensed by a licensed pharmacist (in a 
pharmacy); however a prescription from a physician is not required. Such products 
must not be stored in a direct access to consumers. 
 
3.4.1.4 Over the counter Pharmacy Medicines (OTC-P):- 
 
These medicinal products may be dispensed without a prescription and sold only in 
pharmacies. Such products may be stored in direct access to consumers. 
 
3.4.1.5 Medicines Sold in Pharmacy & Non Pharmacy Outlet (OTC-G):-  
            These medicinal products may be sold in pharmacies and outlets such as 
supermarkets with controlled storage conditions. Acquisition must be made 
through licensed medical store only. 
 
Despite, some parts of the pharmaceutical legislation are inclusive; they can only be 
effective to the extent that they are adhered to. For example the law restricted the sale of all 
prescription medicines without prescriptions. However in reality strict adherence to the law 
only applies to some medications like narcotics, hypnotics, tranquilizers and other agents 
 
that can cause dependence and addiction, therefore there is a  wide range of prescription 
medicines   including   antibiotics,   asthma   inhalers,   insulin   and   other   anti-diabetics, 







































































4.1 Definition of Antibiotics: 
 
Antimicrobials have revolutionized the treatment of infectious disease revolving life- 
threatening diseases into more manageable and treatable conditions. In general 
antimicrobials are medicinal products that kill or stop the growth of living micro organisms 
and include antibacterial agents (more commonly referred to as antibiotics which are active 
against bacterial infections). Antimicrobials are different from antibiotics in that they can 
be either natural or synthetic substances which kill or inhibit the growth of viruses, fungi 
and parasites in addition to bacteria. [33, 34]Antibiotics are originally natural products, made 
from either bacteria or fungi, which kill or inhibit the growth of bacteria which causes 
diverse diseases. 
According to ATC/DDD: Antibiotics‘ are all substances of ATC group ‗J01‘ (Antibiotics 
for systemic use). ‗Antimicrobials‘ are all substances of ATC group ‗J‘(anti-infective for 
systemic use, including antibiotics for systemic use, antimycotics for systemic use, 
antimycobacterials, antivirals for systemic use, immune sera,   immunoglobulins and 
vaccines. Antiparasitic products (antiprotozoals, antihelminthics and ectoparasiticides) are 
assigned to ATC group ‗P‘ and are thus not included. [35] 
4.2 Characteristics 
 
Despite the diversity of antibiotics with regard to their physical, chemical structure, 
pharmacological  property  and  mechanism  of  action,  all  exhibited  and  excrete  their 
selective toxicity to be effective in treating the infections without being harmful to the 
host, based on this diversity, antibiotics can be classified into the followings: 
Bacteriostatic Versus Bactericidal Drugs 
 
Antimicrobial drugs are classified as either bacteriostatic or bactericidal. For such bacterial 
activity the in vitro tests are very important, therefore; many microbiological techniques 
are used to determine the bactericidal activity of antibacterial agents against different 
isolates including the minimum bactericidal concentration (MBC), time-kill curve, and
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serum bactericidal titer (SBT) as well as minimum inhibitory concentration (MIC) for 
bacteriostatic activity 
Bacteriostatic agents: arrest the growth and replication of bacteria at serum levels 
achievable in the patient, thus limiting the spread of infection while the body‘s immune 
system attacks, immobilizes, and eliminates the pathogens. 







The chemotherapeutic spectrum of a particular drug refers to the species of organisms 
affected by that drug. 
Narrow spectrum 
 
Chemotherapeutic agents acting only on a single or limited group of microorganisms are 




Extended  spectrum  is  the  term  applied  to  antibiotics  that  are  effective  against  gram- 
positive organisms and also against a significant number of gram-negative bacteria. For 
example, ampicillin is considered to have an extended spectrum because it acts against 
gram-positive and some gram-negative bacteria. 
Broad spectrum 
 
Drugs such as tetracycline of broad spectrum antibiotics can drastically alter the nature of 
the normal bacterial flora resulting in a super infection of an organism. [19]
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4.3 Mechanism of action of antibiotics 
 
    Inhibition of cell wall synthesis 
 
 
β-lactam and glycopeptides interferes with the production of peptidoglycan (layer in the 
bacterial cell wall ) by binding to bacterial enzymes known as penicillin-binding proteins 
(PBPs). or transpeptidases; which in turn inhibits the final transpeptidation peptidoglycan 
synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. [38] 
    Inhibition of protein synthesis: 
 
 
Interferes with bacterial protein synthesis by binding to 30S and 50S ribosomal subunits 
resulting in a defective bacterial cell membrane , The target of agents acting through this 
mechanism (aminoglycosides , tetracycline , spectinomycin , chloramphenicol , 
erythromycin, clindamycin, linezolid, Fusidic acid) is the polysomes (polyribosomes) in 
the bacterial cytoplasm. Depending on the agent, these may or may not be degraded. [39] 
    Folate Antagonists 
 
 
Because of their structural similarity to Para-Amino Benzoic Acid (PABA) they interfere 
with bacterial growth by inhibiting bacterial folic acid synthesis through competitive 
antagonism of PABA, resulting in inhibition of Folate synthesis (Sulfamethooxazole) or 
Folate reduction (Trimethoprim) or both (Co-trimoxazole) [40] 
    Inhibition of nucleic acid function or synthesis 
 
 
-    Inhibition of bacterial DNA gyrase 
 
 
The fluoroquinolones, quinolones and nirtofurantoin enter the cell by passive diffusion 
through water-filled protein channels (porins) in the outer membrane. Intracellularly, they 
uniquely inhibit the replication of bacterial DNA by interfering with the action of DNA 
gyrase (topoisomerase IV) during bacterial growth and reproduction.
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-     Inhibition of bacterial RNA synthesis 
 
 
These agents inhibits bacterial RNA synthesis by binding to the bets subunit of DNA 
 
dependent RNA polymerase, resulting in blockage of RNA transcription (Rifampin)[41,42] 
 
4.4 Post-antibiotics effect: (PAE) 
 
PAE is one characteristic of pharmacodynamics is defined as the delayed re-growth of 
bacteria following exposure to an antibiotic In spite of the increasing interest in the PAE as 
an important parameter for its major clinical relevance in designing the antibiotic dosage 
regimen  and frequency of administration of a drug, knowledge on this phenomenon is still 
incomplete, but has been suggested that an alteration of DNA function is possibly 
responsible for post antibiotic effect following the observation that most inhibitors of 
protein and nucleic acid synthesis (aminoglycosides, fluoroquinolones, tetracyclines, 
clindamycin ect.) induce long-term PAE against susceptible bacteria. Theoretically, the 
ability of an antibiotic to induce a PAE is a hallmark of an antibiotic since they use to 
preserve their effectiveness and ability to suppress the growth of the bacterium, despite the 
fall of their concentration below the Minimum Inhibitory Concentration (MIC) for the 
bacterium. Factors that affect the duration of the post antibiotic affect include duration of 
antibiotic exposure, the nature of the antibacterial drug and its concentration and the 
bacterial species, and also environmental factors such as temperature, pH, pO2, growth 
medium. 
Most antimicrobial agents produce a PAE when tested against gram-positive cocci. 
However, beta-lactam antibiotics (except for imipenem) have a minimal against gram- 
negative bacilli, or even a negative.PAE [43, 44, 45, 46, 47]
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4.5 The role of antibiotics 
 
The indication of antibiotics was noted as either therapeutic or prophylactic. 
 
4.5.1 Therapeutic indication 
 
Selection  of  the  most  appropriate  antimicrobial  agent  requires  knowledge  of  several 
factors. The use of antibiotics for treatment can be either for: 
 Specific therapy: This is applicable only, when there is a certain isolated 
micro- organism known as causative agent with well recognized antibiotic 
susceptibility. 
 Empiric Therapy: Some critically ill patients require empiric therapy, which is 
immediate administration of antibiotic(s) covering infections caused by both gram- 
positive and gram-negative microorganism. 
For proper and ideal selection of antimicrobial agent to treat an infection, the 
following principles should be considered: [48, 49] 
-     Identification of the organism and its drug sensitivity establishment: 
 
Rapid assessment of the nature of the organism using different methods for 
culture e.g. disk diffusion, rapid diagnostic tests (RDTs) etc. 
-    The effect of the site of infection on the therapy: 
 
Adequate levels of an antibiotic must reach the site of infection in order for the 
invading microorganism to be effectively eradicated. Some natural barriers may 
cause inadequate penetration of the drug into certain tissues such as the brain, 
prostate, and bone, although inflammation can influence the response to drug 
therapy in these tissues. 
-    Status of the patient: 
 
When selecting an antibiotic, attention must be paid to the condition of the 
patient in terms of his immune system, renal and hepatic function, pregnancy, 
lactation and age.
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-    Safety of the agent: 
 
Many of the antibiotics, such as penicillin‘s, are among the least toxic of all 
drugs,   because   they   interfere   with   a   site   unique   to   the   growth   of 
microorganisms.  Other antimicrobial agents (for example-e.g., 
chloramphenicol) are less specific and reserved for life-threatening infections. 
 
-    Cost of therapy: 
 
Often, several drugs may show similar efficacy in treating an infection, but vary 
widely in cost, example, the triple therapy regimen for eradicating the gram- 
negative bacillus Helicobacter pylori. 
 
4.5.2 Prophylactic Indication: 
 
Prophylaxis was defined as ‗no evidence of infection at the start of the antibiotic course‘. 
Certain clinical situations require the use of antibiotics for the prevention rather than the 
treatment of infections. Since the indiscriminate use of antimicrobial agents can result in 
bacterial resistance and super-infection, prophylactic use is restricted to clinical situations 
in which benefits outweigh the potential risks. The duration of prophylaxis is dictated by 




4.6 Why are antibiotics important? 
 
Only an effective and timely therapy by a very suitable antibiotic can assuage and cease the 
infectious diseases which face the population across the globe.  Nonetheless, there is not 
going to be an end for the perseverance and endeavor to overcome this situation, 
considering the prevalence trend of the disease. More than one third of the world‘s 
population is likely infected by bacterial pathogens. Despite the existence of antibiotic 
therapies, respiratory infections, tuberculosis (TB), and malaria continue to persist as major
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public health threats in the 21st century. For instance, one third of the world‘s population is 
 
currently infected with TB and almost 9 million people have active TB disease. 
 
According to the WHO report ―Priority Medicines for Europe and the World‖, infectious 
diseases rank as the highest total burden of disease worldwide as measured in  Disability 
Adjusted Life Years (DALYs) —31% of the total burden. In fact, infectious diseases were 
identified as the second leading cause of death in the world, placing second in terms of 
global mortality rates, 2.47 deaths per 1000 (slightly behind cardiovascular diseases, 2.63 
deaths per1 000). In 2004, infectious diseases accounted for more than a quarter of deaths 
 
at the global level (26.94%). Approximately 2 million fatalities occur per year from 
bacterial infections. In particular, pneumonia and diarrheal diseases kill approximately 3.8 
million children under 5 each year. (Mossialos et al., 2008) [50] 
Despite  these  facts,  antibiotics  still  have  an  overpowering  therapeutic  value  and  are 
 
necessary for the treatment of many bacterial pathogens and infectious diseases. Therefore, 
continuous investment into the search for new agents of antibiotics with novel mechanisms 
of action (MoA) becomes necessary as resistance spreads and the global burden of 
infectious diseases continues to surge. 
Appropriate use of antibiotic, will definitely reduce the mortality, morbidity, costs, and 
burden of resistance to antibiotics. [51; 52; 53]
26  
4.7 Risk of Antibiotic Use 
 
4.7.1 Adverse drug reactions (ADRs): 
 
An adverse drug reaction (ADR) is a response to a drug which is noxious and unintended, 
and which occurs at doses normally used in man for the prophylaxis, diagnosis, or therapy 
of disease, or for the modifications of physiological function [54] 




4.7.1.1 ADR Vs. an adverse event 
 
 An adverse event is any undesirable event experienced by a patient whilst 
taking a medicine, regardless of whether or not the medicine is suspected to be 
related to the event. An example of an adverse event is a patient being hit by a 
car while on a specific medication. 
 
 An adverse drug reaction is any undesirable experience that has happened to the 
patient while taking a drug that is suspected to be caused by the drug or drugs. 
An example of an ADR could be a patient experiencing anaphylaxis shortly 
after taking the drug. 
 
4.7.1.2. Classification of adverse drug reactions 
 
Adverse drug reactions are frequently classified into six different categories [55, 56]. These 
are: 
    Type A Reactions 
 
 
Type A, also known as the augmented reactions are a consequence of 
magnification of the desired pharmacological action of a drug after the normal 
therapeutic dose, and are normally dose-dependent. Respiratory depression with 
opioids or bleeding with warfarin, are perfect examples.
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This class may also include those reactions that are not directly associated to the 
pharmacological effects of the drug. Type (e.g. dry mouth that is associated with 
tricyclic antidepressants). 
    Type B Reactions 
 
 
Type B is also recognized as bizarre reactions are new pharmacologically 
unexpected reactions of the drug.  Reactions of this class are less frequent These 
are less common, and so may only be discovered for the first time after a drug has 
already been made available for general use. Examples include anaphylaxis with 
penicillin or skin rashes with antibiotics 
 
    Type C Reactions 
 
Type C, or ‗continuing‘ reactions, persist for a relatively long time.  For example 
the osteonecrosis of the jaw with bisphosphonates. 
 
    Type D Reactions 
 
Type D which are the ―delayed‖ reactions, become apparent some time after the use 
of a medicine. The timing of these may make them more difficult to detect. 
Leucopoenia, which can occur up to six weeks after a dose of lomustine, is a known 
example of them. 
 
    Type E Reactions 
 
Type E, or ‗end-of-use‘ reactions, are associated with the withdrawal of a medicine. 
An example is insomnia, anxiety and perceptual disturbances following the 
withdrawal of benzodiazepines.
 





Drug ADRs Cautions Contraindications 









Cephalosporines allergic reactions, 
anaphylaxis Nephritis and 






Erythromycins GIT disturbances, 
reversible cholestatic 
hepatitis with estolate salt. 
Hepatic 
impairment 
Avoid estolate salt in 
pregnancy and in 
hepatic disease 
Fluoroquinolones tendinitis and tendon 
rupture , GIT disturbances , 






Penicillines Allergic reactions, 
anaphylaxis 
History of allergy, 
renal impairment. 
Avoid ampicillin and 
amoxicillin. 
Tetracyclines Discolouration and 
deformity in growth teeth , 








failure, children under 
12 years old. 
Sulphonamides Allergy , 
agranulocytosis,Stevens- 
Johnson syndrome , 






Pregnancy , infants 




Vancomycin Ototoxicity , reversible 


























4.7.2 Drug Interactions: 
 
These can be either kinetic, e.g. enzyme induction or inhibition or dynamic, e.g. two drugs 
negatively affecting the same organ. Examples include the followings: 
1- Aminoglycoside Antibiotics 
 
Aminoglycosides should be avoided during pregnancy because of the high of 
 
risk of foetal ototoxicity, therefore concurrent use of other ototoxic drugs, e.g. high 
ceiling diuretics, minocycline and also concomitant use of nephrotoxic drugs, e.g 
amphotericin B, vancomycin, cyclosporine and cisplatin should be highly 
restricted. Using aminoglycosides in middle aged and patients with kidney failure 




Tetracyclines cross the placenta and could be excreted in breast milk. 
Therefore they should be avoided during pregnancy and lactation. With patients 
who suffer from renal or hepatic problems tetracyclines should also be given with 
caution. They may raise blood urea levels, so their co-administration with diuretics 




Chloramphenicol interacts with tolbutamide, chlorpropamide, warfarin, 
cyclophosphamide and phenytoin by inhibiting their metabolism; so toxicity 
occurrence is most possible if dose adjustments are not done. Failure of therapy 
may occur with concomitant use with Phenpbarbitone, phytoin, rifampin because 




The co-administration of sulfonamides with phenytoin toblutamide and 
warfarin leads to the enhancement of the effect of these drugs. This is because it
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inhibits their metabolism and it also displaces their protein binding.  Sulfonamides 





Co-administration of theophylline, caffeine and warfarin with Quinolones 
mainly ciprofloxacin, norfloxacin and pefloxacin increase their plasma 
concentration due to inhibition of their metabolism thus toxicity of these drugs may 
occurs. Seizures are reported with non-steroidal anti-inflammatory drugs 
(NSAIDs). QTc interval prolongation occurs when using quinolones concomitantly 
with antiarrhythmics (e.g., class IA and III agents). Increased serum digoxin is 




Erythromycin and other macrolides inhibit hepatic oxidation of many drugs 
resulting in a rise of the plasma levels of theophylline, carbamazepine, valproate, 
ergotamine and warfarin, where INR should be carefully monitor. Inhibition of 
CYP3A4 leads to Q-T prolongation; serious ventricular arrhythmias and death have 
been reported. [62] 
 
7- Beta-Lactams 
Ceftriaxone IV and IV calcium-containing solutions should not be 
administered within 5 days of each other to patients aged less than 10 weeks due to 
 
the risk of cardiopulmonary adverse events in neonates associated with 
 
precipitation of a ceftriaxone-calcium salt in the lung and/or kidneys. But for all 





Drug therapy, particularly with broad spectrum antimicrobials or combinations of agents, 
can lead to alterations of normal microbial flora of the upper respiratory, intestinal and 
genitourinary tracts, permitting the overgrowth of opportunistic organisms, especially 
fungi or resistant bacteria. These infections are often difficult to treat. Superinfection is a 
common cause of treatment failure and high economic burden. For instance, superinfection 
caused by stenotrophomonas maltophilia and Pseudomonas aeruginosa. Following 
imipenem therapy, vaginal overgrowth of candida or of resistance staphylocooci in the 
intestinal flora associated with tetracycline. [63; 64]
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4.7.4 Antibiotics Resistance 
 
4.7.4.1 What is Antibiotic Resistance? 
 
Antibiotic resistance is a complex process which results from the use and misuse of 
antibiotics. It is a process by which bacteria changes and develops properties that make the 
drugs used to treat them ineffective. [50] 
Severity of Antibiotic Resistance 
 
Antibiotic resistance has become a day to day challenge of very major magnitude to local, 
national, and global public health; therefore the possibilities of effectively treating 
infectious diseases have been substantially reduced because of resistant bacteria. 
Furthermore, the risks of complications, morbidity and mortality for patients [65] have been 
much increased due to antibiotic resistance.  It is well known that the third leading death in 
the EU is due to infectious diseases [66].   The problem is further complicated and risks are 
escalated as resistance to entire antibiotic classes (e.g. β-Lactams, Quinolones, 
Tetracyclines, Glycopeptides and Macrolides) is also emerging rapidly. (Mossialos et al. 
2008) [50] 
 
Antibiotic resistance trends in developing countries 
 
In developing countries, owing to the fact that antibiotics are available over the counter; 
which leads to self-medication and inappropriate use of antibiotics, a very high level of 
resistance has been noticed. 
In view of the absence of access to more affordable and effective antibiotics [67], resistance 
 
in developing countries often leads to death.
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4.7.4.2 Causes of Antibiotic Resistance: 
 
Following are the two reasons for the cause of growth in antibiotic resistance: 
 
    Related to how antibiotics are used in practice 
 
 Related to insufficient investment in to research for diagnostics and 
antibiotics 
4.7.4.2.1 Reasons related to the use of antibiotics:- 
 
    Misuse of antibiotics: 
 
Differences in the consumption and prescribing patterns of antibiotics depends on the 
incidence of CA infections, cultural and social determinants, pharmaceutical market, 
regulatory practices, public knowledge about antibiotics and resistance, and the healthcare 
system, structure and resources. [68] Numerous studies confirm that increased antibiotic 
consumption is associated with the emergence of antibiotic resistance worldwide [69] 
In order to determine whether or not, policies encouraging reduction of 
antibiotic consumption can in fact slow the rapid spread of resistance, it is 
imperative to compare antibiotic consumption trends to rates of antibiotic 
resistance. 
    Physicians and healthcare providers: 
 
It  is  a  present  day  challenge  to  HCPs  (Health  care  providers)  as  far 
antibiotic resistance is concerned. 
Limiting the emergence of antibiotic resistance and curtailing its spread by 
treating effectively infectious diseases is the need of the hour.Inappropriate 
diagnosis and wrong prescription by the health care professionals for e.g. 
for very common cold is almost 55% of prescriptions of all antibiotics in the 
U.S.  In the year 2001, in the U.S, it has been documented that unnecessary 
prescription for upper respiratory tract infections amounts to the above 
figure of 55%.It warrants a more focused approach by all HCPs [70]
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    Negative externality: 
 
Public health benefits of antibiotic consumption will be very much 
diminished by the negative externality associated with antibiotics resistance 
[50] 
 
    Livestock and agriculture: 
 
Apart from the inappropriate prescriptions and over‐consumption of 
antibiotics,   livestock too, get affected due to the acceleration of antibiotic 
resistance, since    antibiotics are used in live stock for growth promotion 
and treatment of infection.   It is worth noting that more than half of all 
antibiotics produced globally are used in animals [71] 
4.7.4.2.2 Reasons related to the insufficient investment into research. 
 
 The role of diagnostics in antibiotic resistance:   Improvement on the use 
of antibiotics as well as reduction in cost and time can be achieved by the 
proper identification of targeted pathogens with rapid diagnostic tests 
(RDTs) [72].       Determination of the precise cause of the infection [73]  has 
been hindered due to lack of suitable RDTs for the health care practitioners. 
 The Role of Vaccines in Antibiotic Resistance:    Contribution of vaccines 
has a tilling effect on the ever growing demand for antibiotics as it has 
reduced the demand for antibiotics to a greater extent and thus slows the 
spread of antibiotic resistance. 
For example, a US study of >37,000 children, heptavalent pneumococcal 
vaccine (PCV7) vaccination reduced first-line antibiotic prescriptions 
by5.7% and second line by 13.3 %. (Mossialos et al., 2008) 
[50]
 
 Lack of New Antibiotics: Let alone the misuse of antibiotics and 
deficiencies of available diagnostic tools, the lack of sufficient development
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of new and novel classes of antibiotics challenges current efforts to slow the 




4.7.4.3 Mechanism of Antibiotics Resistance: 
 
A.  Genetic alterations leading to drug resistance 
 
 
Resistance develops due to the ability of DNA to: 
 
 
 Spontaneous mutations of DNA:   An example is the emergence of 
Rifampin resistant Mycobacterium tuberculosis when Rifampin is used 
as a single drug) 
 
    DNA transfer of drug resistance: 
 
 
B.  Altered expression of proteins in drug-resistant organisms: 
 
 
Following mechanisms mediate the drug resistance: 
 
 





 Decreased accumulation: This might be due to the presence of an 
efflux system that pumps out the drug (Tetracyclines, Primaquine). 
 
 Enzymatic inactivation:  The ability to destroy or inactivate the 
antimicrobial agent also can confer resistance on microorganisms. For 
example, B-Lactamases destroy many Penicillins and Cephalosporins 





4.7.4.4 Cost of Resistance: 
 
 
Three components are involved in the financial burden on resistance: 
A. Direct Medical Costs. 
It includes the following: 
 
 
i.         longer length of hospital stay 
 
 
ii.         Increased costs within services 
 
 
iii.  An increase of the expenses that will be paid in the control 
measures of isolation and infection 
 
iv.        Increased frequency of surgical intervention and other 
complication. 
 
B.  Organizational and Infrastructure Costs. 
 
 
I.   Maintaining surveillance programmes. 
II.   Central reference laboratories 
 
C.  Indirect Costs. 
 
 
Potential loss stemming from morbidity and mortality among those 
with drug-resistant infections. [76] 
 
4.7.4.5 Strategies to overcome antibiotic resistance: 
 




To contain the antimicrobial resistance, WHO has identified several interventions 
addressing the message to all the concerns (patients, prescribers, dispensers, health 
authorities, pharmaceutical manufacturers etc) focusing and targeting [77]:
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a. Reduction of prescribing, with particular emphasis on those drugs 
whose consumption has been shown to correlate strongly with 
resistance; 
 
b. Development of new formulations or dosing schedules of those 
drugs whose pharmacodynamic parameters are better suited to cope 
with highly resistant strain 
 
c. Encouraging the use of antibiotics with the maximal capability of 
bacterial eradication. 
 
d. Training of prescribers and dispensers. 
 
 
e. Developing national drugs policies and guidelines. 
 
 
f. Reducing the use of agricultural antibiotics. 
 
 
g. Encouraging the development of appropriate new drugs and 
vaccines.
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The Centre for Disease Control and Prevention (CDC): 
 
CDC contributed in overcoming the antibiotic resistance by conducting a campaign to 
prevent Antimicrobial Resistance, that concluded four recommendations [78]; 
-    Prevent infection 
 
 
-    Diagnose and treat infection effectively 
 
 
-    Use antimicrobial wisely 
 
 
-    Prevent transmission 
 
 
Tracking antibiotics resistance in the UAE is very humble, since only few studies had 
been carried out. 
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4.8 Factors influences use of antibiotics 
 
In order to support the rational use of drugs, it is important to collect information on 
patterns of drug prescriptions and on factors influencing prescribing decisions. Contributed 
factors are related to: [83; 84; 85; 86] 
- Behavioral characteristics of doctors (Prescribers) 
 
- Behavioral characteristics of patients. 
 
- Laxity in regulation of prescribing and dispensing antibiotics 
 
4.8.1 Behavioral characteristics of doctors (Prescribers): 
 
 Diagnostic uncertainty: Sometimes it is difficult to diagnose at the early stages 
whether an infection is viral or bacterial, especially in cases of upper respiratory 
tract infections and diarrhea. 
 Patient  expectation  and  demand:  Some  patients  who  had  in  the  past  been 
prescribed antibiotics asked to be given these drugs again. Educated patients also 
named antibiotics that they wanted. Doctors often yield to patients‘ demand or 
expectations for prescribing antibiotics. 
 Fear of poor patient outcome: occasionally patients are not satisfied with other 
treatment than antibiotics, so doctors feel they must prescribe the antibiotic to 
satisfy them. 
 
 Lack of time due to overcrowding: Doctors, especially those in public sector do 
not offer enough time to study the patient‘s case history, do a proper physical 
examination or educate them 
    Economical incentive from pharmaceutical companies: 
 
 
Newly  launched  antibiotics  were  prescribed  on  the  advices  and  recommendations  of 
medical representatives who present the doctors with conflicting non randomized studies in 
favor of the antibiotic they are promoting.
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    Over-stock of drugs and near-expiry drugs: 
 
 
To use the entire stock before it expires, dispensing doctors prescribe these drugs even 
though they may not be required by the patient. 
4.8.2 Behavioral characteristics of patients: 
 
Patients’ misperceptions 
Beliefs  and  confidence  of  patients  that  antibiotics  are  the  most  effective  against  all 
infections, regardless of the reasons for these infections, and their  etiology , leading them 
 
to often request antibiotics from doctors. [87].  Lee and co-workers in their study revealed, 
that, out of 197 families in observational, prospective cohort study, there were 53.0% 
believed that antibiotics were needed to treat colds [88]. Most of the patients, who visited 
their  doctors  with  acute  lower  respiratory  symptoms,  come  with  expectations  that 
antibiotics will be prescribed for them. These expectations have significant influence on 
prescribing, even when their doctor judges that antibiotics are not indicated [89]. Pshetizky 
and associates asserted that a short explanation by the family physician to the child‘s 
parents about the disease and the probable spontaneous improvement could reduce 
antibiotics use by 50.0% in children with acute otitis media [90]. A study conducted in 
suburban area near New Jersey came across that parents in the suburban setting were more 
expected to have inappropriately used antibiotics for their children. Conversely, those in 
the urban setting were more likely to have been discharged by a physician at one health 
facility and gone to another physician‘s office in order to obtain antibiotics for their 
children [91]. 
Self-medication with antibiotics 
 
The WHO has defined self-medication as the use of drugs to treat self-diagnosed disorders 
or symptoms, or the intermittent or continued use of a prescribed drug for chronic or 
recurrent disease or symptoms 
[92]
.  Self medication with antibiotics is frequently
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considered one of the factors contributing to drug resistance [93].  A study performed in 
 
Turkey on a population that has access to primary healthcare services and a physician, 
 
19.1% were found self-administering antibiotics. [94] 
 
A Russian study revealed that 83.6% of nine hundreds families were keeping antibiotics 
for systemic use in their homes, 86.2% out of them declared that they are using antibiotic 
without a physician‘s consultation [95]. 
Patients’ adherence 
 
Adherence to the prescribed regimen or treatment is defined as ‗the patient‘s tendency to 
follow   medical   advice.    [96].   Any   non-compliance   for   any   reasons   like   treatment 
affordability,  might  leads  to  withdrawal  of  medications,  and  certainly  worsening  of 
patient‘s condition [97]. Pechère and co-workers in their multinational study concluded that, 
there was a poor understanding in 10 of the 11 countries of how non-compliance can 
increase the potential for resistance development. [98]. A study conducted in a sample of 509 
eligible participants, (individuals prescribed a new antihypertensive monotherapy), of 
which 118 (23.2%) reported non-compliance with their drug treatment [99].
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4.8.3 Antibiotics policy 
 
4.8.3.1 What is a national drug policy? 
 
A national drug policy is an obligation to a target and a map-reading for action. It conveys 
and prioritizes the medium- to long-term purposes set by the government for the 
pharmaceutical sector, and recognizes the main strategies for achieving them. It provides a 
frame work within which the activities of the pharmaceutical sector can be synchronized. It 
covers both the public and the private sectors, and involves all the main actors in the 
pharmaceutical field. [100, 97] 
4.8.3.2 Why a national drug policy? 
 
The general objectives of a national drug policy are to ensure: 
 
Access: equitable availability and affordability of essential medicines, including traditional 
medicine; 
Quality: the quality, safety and efficacy of all medicines; 
 
Rational use: the promotion of therapeutically sound and cost-effective use of medicines 
by health professionals and consumers. 
Regarding antibiotic policy the WHO recommendation to the government policies are: 
 
-       To stick upon only-prescribing available antimicrobials. 
 
- To ensure that only antimicrobials meeting international standards of quality, 
safety and efficacy are granted marketing authorization. 
4.8.3.3 UAE Antibiotic Policy: 
 
According to the national antibiotics policy and guide to antimicrobial therapy, 
antimicrobial should only be sold or supplied by prescription of an authorized medical 
practitioner or dentist. For purpose of rational use, antimicrobials are classified into three 
groups according to the prescribing levels: 
-     Group A: Antimicrobial for common use, all practitioners may prescribes them 
 
(Safe, effective and relatively cheap)
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- Group B: Restricted, are for prescription by specialists (expensive, toxic and 
new agents) 
- Group C: For use in primary health care (same like group A) with some 
omissions [101]. 
Owing to enormous changes that extended since 1998, when the antibiotics policy of the 
UAE was published, therefore this policy should be re-formulated and arranged in line 
with current health requirements and recent evidence-based medicine. 
 
4.9. Newly invented and in the pipeline antibiotic agents: 
 
It  is  known  that  antibiotics  are  the  only  group  of  medicinal  products  which  are  not 
primarily targeting the human tissue. During the last few years some new antimicrobial 
agents been introduced. 
1- Aminoglycosides: Neoglycosides. 
 
a.   Plazomicin 
 
It was known ACHN 490. It is the First member of the neoglycoside. 
 
Plazomicin   is   resistant   to   enzymatic   inhibition. [102]    It   inhibits 
bacterial protein synthesis and exhibits dose-dependent bactericidal 
activity. It has a Broad spectrum activity against Gram-negative and 
Gram-positive   bacteria.   Due   to   its   lower   minimum   inhibitory 
 
concentration (MIC) it‘s active against Acinetobacter.[103] There is no 
evidence of ototoxicity or nephrotoxicity. [104] 
2-  Quinolones 
 
a. NXL 101: 
 
It is primarily an inhibitor of topoisomerase IV. It is used mainly against gram 
negative bacteria and MRSA. Unfortunately, use of NXL 101 is associated with 




It is in phase II studies.  Delafloxacin is active against S. aureus including 
MRSA. It is suitable for infections in low pH environment such as the skin, 
vaginal tract, urinary tract and intracellularly within the phagosomes. 
c. Nemonoxacin 
 
It is in phase II studies. Nemonozacin is a non-fluorinated quinolone active 
against pathogens that cause CAP. [107] 
d. ACH 702 
 
It is an isothiazoloquinolone, which is highly active against MRSA including 
biofilms. ACH 702 is also active against a wide range of Gram-negative bacilli 
as well as Mycobacterium tuberculosis. [108,109] 
e. Quinazolinediones 
 
It is active against GyrB "gyrase B gene"and ParE ―topoisomerase IV‖ enzymes. 




Tedizolid and radezolid are two new oxazolidinone that offer an improvement 
over linezolid .Tedizolid MICs are lower compared with linezolid for 
staphylococci, streptococci and enterococci. Tedizolid is active against MRSA 
that possess the cfr gene‖ cfr gene encodes a methyltransferase‖. [111] 
g.    Radezolid. 
 
It achieves higher levels inside macrophages and neutrophilsit is useful when 
applied to persistent infections with intracellular organisms. [111, 112] 
h.    Sutezolid 
 








Ceftaroline is a fifth generation cephalosporin. It is active against MRSA (and 
also vancomycin resistant S. aureus). [114] 
b. Avibactam (NXL 104): 
 
It inhibits β lactamases. It has a Broad spectrum of activity including the KPC 
enzyme  ―Klebsiella  pneumoniae  carbapenemase‖  family.  Ceftazidime- 




Cethromycin and Solithromycin are two new ketolides in development. 
Cethromycin has an orphan drug approval by the FDA for the treatment of 
bioterrorist threats such as anthrax and plague. Both are highly active against 
Gram-positive organisms but modestly active against Gram-negative bacteria. 
[116] 
 
The main indication of Solithromycin would probably be skin and soft tissue 





It is a broad-spectrum glycylcycline. Tigecycline is not a substrate for drug 
efflux or the ribosomal protection proteins, mechanisms that lead to resistance 
to tetracyclines. It is useful in the treatment of mixed infections if Pseudomonas 




It is similar to tigecycline in its spectrum but unlike the latter, it is absorbed 
orally. TP-434 is new compound which shares several properties with 
omadacycline. It given once daily intravenous (I.V.). [114] 
 
5. Newer glycopeptides. 
a. Telavancin: 
 
It is a newly licensed lipoglycopeptide. Telavancin is used for the treatment of 
 
Hospital-Acquired Pneumonia (ATTAIN) trials showed that the cure rates with 
telavancin   was   58.9%   compared   with   59.5%   with   vancomycin   (95% 
confidence interval for the difference, -5.6% to 4.3%). In the subset analysis, 
cure rates were higher with telavancin in patients with monomicrobial 




It is a synthetic derivative of chloroeremomycin.    Oritavancin inhibits 
transglycosylation by binding to the terminal D-alanyl-d-alanine and also binds 
to the Pentaglycyl Bridge in the peptidoglycan moiety. It‘s active against 
vancomycin-resistant enterococci and VRSA. Oritavancin has long half-life and 



















































































Over –the –counter acquisitions of antibiotics in some countries (e.g. Sudan) are with high 
frequency due to the lack of laws restricting antibiotic sales or a failure to enforce those laws. 
Studies showed that approximately 70.0% of the world‘s antibiotics are used in the 
community. These high rates of using these powerful agents may negatively affect their 
efficacy and resulting in increasing prevalence of resistance. In 2000, the WHO Report 
"Overcoming Antimicrobial Resistance" identified three key issues for public involvement: 
improving access to medical services, reducing unnecessary use of antimicrobial drugs and not 






The  aim  of  this  study  is  to  assess  current  knowledge,  attitudes  and  behaviour  towards 
antibiotics (ATB) among banking employees. 
Specific objectives: 
 




    Evaluate parents‘ awareness of antibiotics use by their children. 
 




5.1.3.1 Study design 
 
A Descriptive-cross sectional study was conducted In Sudan, Oman and UAE. 
 
5.1.3.2 Study settings 
 
The study was carried out in several central bank branches in the capitals of the above 
mentioned countries. 
5.1.3.3 Study population 
 
Despite the differences in these regions in terms of the socio-economical status (impact on 
purchasing power) climate (type of existed diseases), but the selected cohort in all these 
regions are fully medically insured (particularly in Sudan, where the banking employees are 
one of the fewest socio-economic groups, who have medical insurance). 
Our study population consisted of n=450 banking employees (n=150 each region) who were 
randomly nominated by the managers of the central banks. Participation was voluntary and 
verbal consent was obtained after briefing the objectives of the study. 
5.1.3.4 Data collection 
 
Data   were   collected   through   a   structured,   pretested,   validated,   self   administrative 
questionnaire (Appendix 1).  The questionnaire collected demographic data such as age, 
gender and level of education of each participant. Respondents were asked, whether they used 
antibiotics during the past year. In order to help the participants to remember the antibiotics 
they  used,  we  provided  a  list  of  the  most  common  used  antibiotics  in  their  countries 
(Appendix 2). Participants, who confirmed their use of antibiotics, were asked why and how 
they obtained their antibiotics, whether they are storing any antibiotics at home, and if they 
intended to use them personally or for their children without a Doctor‘s prescription or advice.
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5.1.3.5 Statistical analysis: 
 
Data obtained was entered into a micro computer running the statistical package for social 
sciences (SPSS version 11.0) soft ware to validate and analyze entries. Descriptive statistics 
were used to describe socio-demographic characteristics of the respondents. Prevalence of 





Out of 450 nominated employees (150 each region) 331 employees participated in the study; 
the rate of response was 64.6%, 74.0%, 82.0% in Sudan, Oman and UAE respectively. 
Respondents‘ Characteristics: 
 
The mean age of respondents was 34 years. Males represented 66.6% of the participants. 198 
(59.8%) of the respondents have children under the age of sixteen. 25% have secondary 
education, 24.5% have secondary vocational education and the rest representing 50.5% are 
with university graduation. Demographic data were presented in Table 8.
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Age 21-30 25 79 37 141 
31-40 38 26 60 124 
41-50 27 5 24 56 
>51 7 1 2 10 
Gender Male 53 81 83 217 
Female 44 30 40 114 
Education Secondary 14 56 13 83 
Secondary 
Vocational 
16 45 20 81 
University 67 10 90 167 








Out of 97 respondents in Sudan 81 (83.50%), while 52 (46.80%) out of 111 and 92 (74.80%) 
out of the 123 respondents in Oman and UAE respectively reported antibiotics use during the 
last year. As shown in Table 9. 
Within the respondents who have children 83.50%, 66.70% and 67.70% in Sudan, Oman and 
UAE respectively reported antibiotic use for their children during the past year. As illustrated 
in Table 10. 
Antibiotic use without prescription: 
 
Among those who reported antibiotic use there are 49.30% in Sudan, 26.90% in Oman and 
 




Within all parents who reported antibiotics use for their children, 20 (13.70%) of them 
reported use of antibiotics without prescription for their children in the past year. It is 
noticeable that this practice is affected by the parents‘ educational level. As shown in Table 
10.
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Region Sudan Oman UAE Total 













*Note: The percentage of Antibiotic use in each region is calculated from the total number of 
respondents in that specific region (e.g. % of Antibiotic use in Sudan (83.50%) is calculated  
from  n=97 (100%)) 
 
** Note: The percentage of antibiotic use without prescription in each region is calculated 
 
from the number of respondents who reported the antibiotic use in that specific region (e.g. % 
 




Table 10.         Antibiotic use among children 
 
 
Region Sudan Oman UAE 
Have children 79 54 65 
Reported antibiotic use for children 66 36 44 
Reported antibiotic use without 
prescription for children 








Secondary 1 1 - 
Secondary 
vocational 
- 2 - 




Note: the percentage of those who reported antibiotic use for their children without 
 
prescription in each region is calculated from the total number of respondents who reported 
 
antibiotic use in that region (% of parents reported antibiotic use for their children in UAE 
 
(6.8% is calculated from total number of those who reported antibiotic use for their children 
 
in UAE n=44) 
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Antibiotics commonly used: 
 
For the respondents and their children the most frequent antibiotic used was Amoxicillin 
(40.90% and 46.60% respectively).This was followed by Amoxicillin/clavulanic acid (45%, 
29%). However Tetracyclin was used by children under sixteen only with prescription 
(2.70%) for acne, while adult respondents used Tetracycline with and without prescription 
(12%).  The frequencies of antibiotics commonly used were presented in Table 11 














Amoxicilin 55 (59.80%) 37 (40.20%) 92 (40.90%) 
Amoxicillin/clavulanic acid 24 (53.30%) 21 (46.70%) 45 (20%) 
Ampiclox 22 (66.60%) 11 (33.40%) 33 (14.70%) 
Tetracyclin 10 (37%) 17 (63%) 27 (12%) 
Cotrimoxazole 
(Septrin) 
5 (55.60%) 4 (44.40%) 9 (4%) 
Erythromycin 7 (58.30%) 5 (41.70%) 12 (5.30%) 









Without prescription (n=20) Total (n=146)** 
Amoxicilin 57 (83.8%) 11 (16.20%) 68 (46.60%) 
Amoxicillin/clavulanic acid 25 (86.2%) 4 (13.80%) 29 (19.90%) 
Ampiclox 19 (86.4%) 3 (13.60%) 22 (15.10%) 
Cotrimoxazole 5 (71.4%) 2 (28.60%) 7 (4.80%) 
Erythromycin 8 (100%) 0 8 (5.50%) 
Cephalxine 8 (100%) 0 8(5.50%) 




*Note: percentage of each used antibiotic with or without prescription is calculated from the 
total number of respondents who reported the use of this specific antibiotic. (e.g. % of with 
prescription use of Amoxicillin (59.8%) is calculated from the total Amoxicillin use n=92)  
 
**Note: The percentage of the total use of each antibiotic is calculated from the total number of 
respondents who reported antibiotic use. (e.g. % of Amoxicilin use 40.9% is calculated from the total 
number of people who reported antibiotic use  n=225)
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Reason for self medication with Antibiotics: 
 
Respiratory tract infections were reported as the leading reason for antibiotic use with or 
without prescription for both the respondents and their children. Reasons for which antibiotics 


































Source of antibiotics obtained without prescription: 
 
Within those who have used antibiotics without prescription (n=98), 5.1% used the antibiotics 
 
based on friends‘ advices; 24.5% had their antibiotics from leftovers from previous illnesses. 
 
Pharmacists‘ dispenses according to the respondents‘ complains shared by 17.3% of the non- 
 
prescribed acquisition of the antibiotics. 53.1% obtained antibiotics as over the counter based 
 
on their own request for the specific antibiotic. As presented in Table 12.  It is obviously 
 
noticeable that the use of antibiotics without prescriptions was to a great extend limited in 
 









Table 12.          Sources of antibiotics obtained without prescription 
 
 
Source Sudan n= 40 Oman n= 14 UAE n=44 Total n=98 
Friend‘s advice 2 (5%) 1 (7.10%) 2 (4.50%) 5 (5.10%) 
Leftovers from 
previous prescriptions 




7 (17.50%) 2 (14.30%) 8 (18.20%) 17 (17.30%) 
OTC based on the 
respondents request 




Note: the percentage of the source of obtained antibiotics without prescription is calculated from 
the total number of respondents who reported antibiotic use without prescription in each region. 
(e.g. % of OTC acquisition I Sudan (52.5%) is calculated from the total number of respondents in 
Sudan who reported antibiotic use without prescription (n=40)).
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5.1.5 Discussion: 
Miss use and overuse of antibiotics beside the emergence of resistance bacteria have also 
resulted in enormous expenditures and adverse drug reactions. In both developed and 
developing countries, many factors have been reported with the overuse and misuse  of 
antibiotics including drug use policies, economics, prescribers‘ knowledge, patients‘ 
expectations, inaccurate diagnoses and pharmaceutical market. 
 
The selected cohort in these regions are fully medically insured (particularly in Sudan, where 
 
the banking employees are one of the fewest socio-economic groups who have medical 
 
insurance). 
In our study we assessed the banking employees' demographic profile in terms of their age, 
gender, educational level and whether they have children below sixteen years old or not with 
regard to their attitude towards antibiotics and if, they used them   with or without 
 
prescription. The study was conducted through a structured, pretested, validated, self- 
 
administrative questionnaire, which has some differences with other questionnaire of similar 
 
objectives in Europe [121] to be harmonized with the intra-cultural conditions in these regions. 
The questionnaire has contributed to a relatively low response rate (73.6%) in comparison 
with studies conducted in US (87%) [122] and Turkey (100%) [123] 
The study participants was composed of 33.4% female while the female participation rate in a 
 
Sudanese and Nepalese studies, was 54.9% and 28% respectively. [122, 124] 
 
The prevalence of self medication with antibiotics within our study group is rated 43.56% 
which is higher than what have been reported in Turkey and Spain 32.2% and 32.1% 
respectively.[123, 125] But it much lower that what been reported from  Lithuania (53.2%). [126]
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The most frequently used antibiotics in our study with or without prescriptions are 
Amoxicillin, Amoxicillin/clavulanic acid combination, Ampiclox, Cotrimoxazole, 
Erythromycin and Tetracylin, in descending order. This pattern was almost similar to those 
from Croatia, Russia, Sudan and Trinidad and Tobago. [127, 128, 124, 129] 
Study results showed that, healthcare providers prescribing antibiotics for respiratory 
 
infections, which were most likely viral in origin. Such a prescription pattern will likely 
contribute to the emergence and spread of resistance. Like many studies.[130, 131] Erythromycin 
which is known to be extensively metabolized by cytochrome P-450 3A (CYP3A) 
isozymes,and it‘s concomitant use with the medication that inhibits the effects of CYP3A may 
increased its plasma concentration, that can cause a ventricular arrhythmias and sudden death, 
been reported as self-medicated and prescribed antibiotics[132, 133]   , which is most probably 
used with some of these agents like, Ketoconazole , Miconazole  , (fungal infection are more 
frequent in UAE and Oman due to humid weather)  quinine the drug of choice for malaria in 




Through all over the globe dispensing antibiotics is subjected to prescriptions but still the 
problem of self-medication with antibiotics is not exclusively in developing countries but it is 
also common in the developed countries. 
Acquisition of antibiotics without prescription used to be through different ways like friends‘ 
advice, over the counter, leftovers from previous prescriptions without consulting a healthcare 
provider. This practice was reported by 24.5% of our study sample which is remarkably 
similar to a US study results (26%). [134]
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Similar to other studies conducted in Sudan, Russia and Trinidad and Tobago our results 
revealed that the most frequent indications and reasons for self-medication with antibiotics 
were as follows: acute respiratory tract infections, toothache, intestinal disorders, urinary tract 
infections and others. [124, 128, 135] 
5.1.6 Limitations of the study: 
Respondents have been selected by the managers according to the availability of the staff at 
the period in which the study was conducted, which may affect a proper sampling selection. 
 
Despite we provided a list of the common marketed antibiotics in these regions respondents 
 







Self-medication with antibiotics is reasonably high within banking employees in Sudan, Oman 
and UAE. Multi factorial interventions are believed to reduce the incidence of this practice 
including: an intensive public health plans; awareness regarding the consequences of self- 
medication with antibiotics throughout health education and restrictions that stop the 
availability of antibiotics without prescription.
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5.2 Study II 
 






Efforts to promote the rational use of drugs have been targeted mainly at the formal health 
care services. This started back in 1970s, when the World Health Organization (WHO) 
introduced the concept of essential drugs. The principle of this concept is that a limited 
number of drugs would lead to better supply of drugs, better prescribing and lower costs for 
health care. Despite the introduction of the essential drug list in some 110 countries at present, 
drug consumption increased worldwide [136].  It could be argued that antibiotics have done 
more to improve public health in the last 50 years than any other measure, however; it is 
estimated that the worldwide market of antibiotics consumes between 100 and 200 x 106 kg of 
products which products [137]. Differences in implementing drug regulations that affect the 
availability of antibiotics in different countries can play an important role in misconceptions 
about antibiotics [138]. 
 
 
Self-medication can be defined as the use of drugs to treat self-diagnosed disorders or 
symptoms, or the intermittent or continued use of prescribed drugs for chronic or recurrent 
disease or symptoms (Awad et al, 2005; WHO, 2000) [124, 139]. A literature review emphasizes 
that there were no published studies in UAE that addressed self medication with antibiotics by 
the community, which places the current study to be one of the rare published data in this 
field.
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Survey results in Europe showed significant differences in public attitudes, beliefs and levels 
of knowledge concerning use of antibiotics, self-medication and antibiotics resistance [138]. 
Overall, only half of the respondents in the survey were aware about antibiotic resistance. This 
awareness was the lowest in countries with higher a prevalence of resistance [139]. 
In Spain for instance, common self-medication with antibiotics might be a consequence of 
poor implementation of and control over the laws and regulations influencing prescribing and 
influences community pharmacy services even more [140]. 
 
 
Many practitioners, veterinarians, breeders, farmers and analysts work on the assumption that 
antibiotics undergo spontaneous degradation. It is well documented that the indiscriminate use 
of antibiotics has led to water contamination, selection and dissemination of antibiotic- 
resistant organisms and alteration of the fragile ecology of the microbial ecosystems. The 
damages caused by the overuse of antibiotics include hospital, waterborne and food borne 
infections by resistant bacteria, enteropathy (irritable bowel syndrome, antibiotic-associated 
diarrhea etc.), drug hypersensitivity, biosphere alteration, and destruction of fragile inter- 
specific competition in microbial ecosystems [141]. The consequences are severe. Infections 
caused by resistant bacteria fail to respond to treatment, resulting in prolonged illness and 
greater risk of death. Treatment failures also lead to longer periods of infectivity, which 
increase the numbers of infected people moving in the community and thus expose the general 
population to the risk of contracting resistant strains of infection [142]. 
 
 
United Arab Emirates (UAE) is a federation of seven gulf emirates with estimated population 
of 4.1 million people of different ethnic groups (79.9 % are expatriates) [143]. The gross 
national product per capita (GNP) is $32000 [144]. Standards of health care in the UAE are
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generally high, reflecting the high level of public spending over the decades since the oil 
boom. Better health provision has been reflected in rapidly improving figures for key 
indicators such as life expectancy and infant mortality rates, which are now at western levels 
[143]. According to the national antibiotics policy and guide to antimicrobial therapy, 
antimicrobial should only be sold or supplied on prescription of an authorized medical 
practitioner. For purpose of rational use, antimicrobials are classified into three groups 











A Descriptive-cross sectional study was conducted during Abu Dhabi Book Fair; in April 
 
2006. Written approval to conduct the study was obtained from the Health Authority of Abu 
 




The study was conducted during the Book Fair days in April 2006, which is annually take 
place in the Cultural Foundation that located in the heart of Abu Dhabi city, the capital of the 
United Arab Emirates .Cultural Foundation is a national independent authority, was created to 
meet the needs of the cultural and civilization in the state to promote the spread of culture and 
plays an essential role in cultural development as an important part of the overall national 
development.
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5.2.3.2 Study population and sample size 
 
The visitors of the Book Fair were invited to participate in the study; verbal consent was 
obtained after briefing the objectives of the study. Selection of the participants was based on a 
systematic random sampling. Every 35th visitor was chosen. 
5.2.3.3 Data collection 
 
Data   were   collected   through   a   structured,   pretested,   validated,   self   administrative 
questionnaire  (Appendix  1).  The questionnaire collected demographic data such as age, 
gender and level of education of each participant. Respondents were asked, whether they used 
antibiotics during the past year. In order to help the participants to remember the antibiotics 
they used, we developed a portrait containing labels from the available types of antibiotics in 
the health premises as shown in Appendix 4. Participants, who confirmed their use of 
antibiotics, were asked why and how they obtained their antibiotics, whether they are storing 
any antibiotics at home, and if they intended to use them personally or for their children 
without a Doctor‘s prescription or advice. 
5.2.3.4 Statistical analysis 
 
Data obtained was entered into a micro computer running the statistical package for social 
sciences (SPSS version 11.0) software to validate and analyze entries. Descriptive statistics 
were used to describe socio-demographic characteristics of the respondents. Prevalence of 
self-medication in the community with antibiotics reported as percentage. P value was 





Out of 1000 invited visitors 860 agreed to participate in the study; the rate of response was 
 
86.0%. Males represented 65.8% of the participants, while females represented 34.2%. The 
age and educational levels were presented in Table 13. Among 860 participants, 485 (56.3%) 
reported antibiotics use during the last year (68.5% of them were males and 31.5 % females). 
There were no significant associations between gender and use of antibiotics use. However; 
use of antibiotics was significantly affected by age p < 0.001 as well as the educational level 
(p=0.023). The frequencies of antibiotics commonly used were presented in Table 14. 
Amoxicillin was the antibiotic most commonly used by the participants and for their children 
(46.3% and 70%‘ respectively), it was followed by amoxicillin/clavulanic acid combination 
(23.9%, 10.8%). However, ciprofloxacin and norfloxacin were used only by adult participants 
and not used for their children.
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Distribution of total No. of 
 
respondent  n = 860 (%) 
Distribution of respondent reported 
 
antibiotic use  n = 485 (%) 
 Gender 
Male 566 (65.8%) 332 (68.5%) 
Female 294 (34.2 %) 153 (31. 5 %) 
Age 
20 – 29 238 (27.7 %) 100 ( 20.6  % ) 
30 - 39 331 (38.5 %) 176 ( 36. 3 % ) 
40 – 49 222 (25.8 %) 159 ( 32.8 % ) 
50> 69    (8.0%) 50   (10. 3 %) 
Education 
Primary 173 (20.1%) 80   (16.5%) 










Antibiotic use wasn’t associated with nor the gender neither the educational level of the 
 
respondents ( p  value=  0.134  and  p  value=  0.023  respectively). Antibiotic use was 
 




Table 14.         Frequencies of used antibiotics 
 
 
No Name of ATB No. of used courses by 
 
adults n=485(%) 
No. of used courses by 
 
children n=360 (%) 
1 Amoxicillin 226 (46.6%) 252 (70%) 
2 Amoxicillin/clavulanic acid 116 (23.9%) 39 (10.8%) 
3 Erythromycin 14 (2.9%) 10 (2.8 %) 
4 Tetracycline 31 (6.4%) 7 (1.9%) 
5 Clarithomycin 12 (2.5%) 4 (1.1%) 
6 Azithromycin 31 (6.4%) 19 (5.3%) 
7 Ciprofloxacin 4 (0.8%) - 
8 Cotrimoxazole 15(3.1%) 6 (1.7%) 
9 Norfloxacine 20 (4.1%) - 
10 Cefuroxime 10 (2.1%) 13 (3.6%) 
11 Cefixime 6 (1.2%) 5 (1.4 %) 














Within those who have used antibiotics, there were (n=485, 55.7%) obtained their antibiotics 
with a prescription either from a physician or a dentist, while the remaining (44.3%) acquired 
their antibiotics without a prescription as self-medication (Table 15). The results have showed 
that method of obtaining antibiotics was significantly affected by the age of the participants (p 
= 0.014). Among parents who confirmed their use of antibiotics for their children (n= 360), 
results revealed that 65.5% have received antibiotics through a prescription and 34.4% without 




Table 15.           Sources of obtaining antibiotics 
 
 
Source Adults n=485(%) Children n=360 (%) 
Physician 222(45.8%) 195(54.2%) 
Dentist 48(9.9%) 40(11.1%) 
OTC from Community pharmacy 140(28.9%) 89(24.7%) 
OTC from abroad 56(11.5%) 28(7.8%) 
Left over 19(3.9%) 8 (2.2%) 
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Reason Adults n=485(%) Children n=360 (%) 
Influenza 157(32.4%) 159(44.2%) 
General infection 119(24.4%) 66(18.3%) 
Toothache 60(12.4%) 61(16.9%) 
Upper respiratory 32(6.6%) 14(3.9%) 
Gastrointestinal 26(5.4%) 12(3.3%) 
Ear infection 11(2.3%) 27(7.5%) 
Genitor-urinary 36(7.4%) - 
Others 44 (9.1%) 21(5.8%) 
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There  were  (n=  393,  45.6%)  out  all  participants  stated  that,  they can  intentionally  uses 
antibiotics as self-medication without a medical consultation, which was significantly affected 
by the educational  level  of the visitors  (p  0.001).  There were (n= 245, 28.5%) out of 
all participants declared that they were keeping antibiotics at home, which they have mostly 
acquired from the community pharmacies without a prescription (Table17). A significant 
association was found between the behavior of keeping antibiotics at home, gender (n= 151 








Respondents‘ characteristics Antibiotics home with 
 
prescription   n =8 (%) 
Antibiotics home without 
 
prescription   n =237 (%) 
Gender 
Male 0(0%) 151(63.70%) 
Female 8(100%) 86(36.30%) 
Age 
20 – 29 5 (62.50%) 33 (13.90%) 
30 - 39 1 (12.50%) 89 (37.60 %) 
40 – 49 1 (12.50%) 91 ( 38.40 % ) 
50> 1 (12.50%) 24 (10.10 %) 
Education 
Primary 2(25%) 32 (13.50%) 
Secondary 0 (0 %) 45 (18.90%) 




  The tendency of keeping antibiotics at home is significantly associated with the age and  
 




This study represents the first published work on irrational antibiotic use through self 
medication with antibiotics at a community level in Abu Dhabi (capital city of the United 
Arab Emirates) and conducted by a cross-sectional study that included a large number of the 
Abu Dhabi‘s Book Fair visitors who sampled based on a systematic random sampling. Every 
35th visitor was chosen. 
 
Despite the UAE‘s declared antimicrobial policy that restricts dispensing of antibiotics 
 
without prescription, our study indicated the availability of these agents over the counter. This 
has revealed the high prevalence of self-medication with antibiotics in the studied population. 
The rate of use of antibiotics (56.3%) was fairly high as compared with results conducted in 
Czech Republic (31.1%), Jordan (23.0%) and Lithuania (39.9%)  [145, 146, 147]. In Lithuania, 
women tended to use more antibiotics than men. Our results have showed that the use of 
antibiotics was not associated with gender, however; it was significantly affected by age (p < 
0.001) and well as educational level (p=0.023). The high prevalence of self-medication that 
was found within the adult participants (44.3%) and their children (34.4%) might be 
anticipated due to the nature of UAE community, which comprises different nationalities 
(79% are expatriates) [143].The majority being from India, Philippines, Pakistan, Europeans and 
 
different Arab countries, where the prevalence of self-medication was also high. For instance, 
the self-medication with antibiotics was, (48.1%) in Sudan and (39.5%) in Jordan and (18%) 
in India [124, 146, 148].This confirms that traditional, social and cultural factors influence the self- 
 
medication with antibiotics, despite being prescription only medicine in UAE. Furthermore, 
this high prevalence might also be attributed to the easy acquisition of antibiotics from the 
community pharmacies. Another reason that might be entailed is the lack of disciplinary
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regulations in antimicrobial policies in UAE. Regarding the reported results from studies in 
Sudan, Jordan and Greece India [124; 146; 149], amoxicillin was the most preferably chosen 
antibiotic even as self medication. Other antibiotics that were used included,amoxicillin  
/clavulanic acid combination , macrolidies, quinilones and tetracyclines.As stated by the 
participants in the current study, influenza had been the major reason that mostly treated by 
prescribed or self -medication antibiotics. This finding, though consistent with results from 
other studies [146, 147; 150], also confirms the belief of the community that antibiotics can treat 
and eradicate any infection irrespective of their origin .It  also revealed  that the participant 
were unaware  of the consequences of inappropriate use of antibiotics. Despite its highly 
harming photosensitivity, our results revealed the inappropriate and irrational use of 
tetracyclines in treating gastrointestinal problems a practice which is in accordance with 
some published guidelines which state the drug is to be used mostly in a combinations with 
other medicines to manage food borne illnesses caused by different types of bacteria (Brucella 
abortus, Vibrio cholerae, Vibrio vulnificus) [151] or for initial H. pylori treatment failure 
regimen (salvage therapy) [152, 153].      Despite its highly harming photosensitivity, our results 
revealed the inappropriate and irrational use of tetracycline in treating gastrointestinal 
problems. This is a practice which is in discordance with published guidelines, which state the 
drug is to be used in combination with other medicines to manage food-borne illnesses caused 
by various bacteria (e.g. Brucella abortus, Vibrio cholera and Vibrio vulnificus) [151] or 




Intended self-medication and storage of antibiotics at home were both considered to be 
predictors of actual self-medication, as reported by Grigogyan and colleagues [121]. Comparing 
our results with those reported from Malta and Czech Republic (22.0%, 7.5% respectively), 
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we found that the main source of obtaining these antibiotics were the local community 
pharmacies. Our study also revealed that retrieving medications from abroad was another 
common source, especially those which were expensive (100% of home stored azithromycin 
in our study were brought from outside the UAE). Participants also declared that another 




5.2.6 Study limitations 
 
The limitation to the current study was related to the sampling of the population. Since our 
sample was drawn from attendees in a book fair. These book-fair visitors were generally 
intellectual and educated. Therefore the sample might not cover the different groups 




The results of the study confirmed that antibiotic self-medication is a relatively frequent 
problem in UAE.  Interventions at different levels are required in order to reduce the 
frequency of antibiotics misuse. Quick and co-workers [154] classified these interventions into 
managerial, regulatory, educational and financial. Managerial interventions: involve work on 
up-dating the antibiotics policy and Guide to Antimicrobial therapy 2nd Edition 1998, establish 
a National Antibiotic Therapeutic Advisory Committee, and establish National Standard 
Treatment Guidelines. Regulatory strategies involve limiting the import of drugs to the market 
[135]. The educational interventions for both prescribers (flow charts, newsletters, bulletins and 
others) and patients/consumers (educational campaigns on antibiotics, their uses and 
limitations) are of paramount importance. With regards the financial intervention: The 
National mandatory health insurance scheme may play an important role to diminish this 
problem.
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5.3 Study III 
 
A comparative study between prescribed and over –the-counter antibiotics 
 
5.3.1    Introduction 
 
United Arab Emirates (UAE) consists of seven Emirates. Abu Dhabi emirate is the largest 
Emirate, which lies on a T-shaped island jutting into the Arabian Gulf from the central western 
coast with an area of 67,340 km2 and estimated 1.85 million population. In 2001 General Abu 
Dhabi Health Service (GAHS) was established; this oversee the running of all Abu Dhabi‘s 
hospitals and primary health centers.  GAHS    also regulate the private health institutes, 
including the pharmacy sector which is composed of community pharmacies and 
pharmaceutical ware houses. In the year 2007 GAHS was replaced by two organizations 
namely; the regulatory body named the Health Authority of Abu Dhabi (HAAD) and an 
operational body named Abu Dhabi Health Services Company (SEHA).The pharmacy practice 
and pharmacies in Abu Dhabi Emirate were regulated according to the UAE Federal Law 
entitled: Article No. 4 (1983) for pharmaceutical profession. 
The alarming global increase in microorganisms resistant to antibiotics poses a major public 
health problem. Although the increasing resistance can be attributed to several factors, a major 
cause is the overall volume of antibiotics consumption. Other contributory factors were, wrong 
diagnosis, indiscriminate prescribing and dispensing errors [155]. The professional activities of 
the community pharmacists have changed completely in arrears to the increasing number of 
available pharmaceuticals including many antibiotics.   In addition to assuring high quality in 
dispensing, responsibilities of the pharmacists have been extended to include detection, 
prevention, and resolution of drug-related problems [155]. Several studies related to the quality 
of dispensing antibiotics, have been conducted. Pharmacists‘ social demographic, educational
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background [156, 157] and opinion about their activity have been considered as the most likely 
determinants of the quality of dispensing [158, 159]. In recent years, one study on antibiotics 
prescribing concluded that small doses and long duration were both associated with increased 
risk of antibiotic resistance. [160] Antibiotics consumption should be reduced to avoid and 
diminish its serious environmental impacts. There are several studies focusing on the 
disproportionate excessive use of antibiotics [161, 162]. Setting a proper antibiotic polices and 
raising the community awareness of the danger behind inappropriate use of antibiotics may 
contribute in diminishing the problem. Promoting the appropriate use of antibiotics through 
various interventions will help to avoid unwarranted prescribing and misuse of antibiotics [155]. 
For appropriate interventions to be carried out across the community, it is important to know 
to what extent the population uses antimicrobials. Enhanced surveillance could play a positive 
role in controlling antimicrobial over-use or misuse. Countries such as Denmark and Spain 
have a database of antibiotics prescribed for all patients in the country. Prescription 
information for various populations (e.g., children versus adults) and between different 
provinces of the country have been analyzed to determine trends in antimicrobial use at the 
population level [163, 164].  OTC dispensing of antibiotics is common especially in developing 
countries. 
In UAE it‘s illegal to dispense an antibiotic without a prescription, therefore we conducted this 
 




The main objectives of this study were: 
 
1. To examine the influence of demographic charateristics (age, gender and years of work 
experience) of the pharmacist with respect to dispensing antibiotics (with and / or without 
prescription) in terms of legalization, rationality and safety. 
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2. To examine the pattern of dispensing antibiotics (with and / or without prescription) in 
terms of frequency, costs and indications (reasons for dispensing). 
5.3.3 Methods 
 
5.3.3.1 Study Design 
 
This was a cross-sectional study, was conducted in Abu Dhabi Emirate, the capital of UAE,. 
Written approval to conduct the study was obtained from Health Authority of Abu Dhabi 
(HAAD), UAE. (Appendix 5). 
The study was conducted during the study period from March to September 2009. 
 
5.3.3.2   Study Settings 
 
The allocation of the study sites was accomplished based on the pharmacies geographical area 
in Abu Dhabi city.  The study carried out in (n= 24) randomly selected community pharmacies 
out of (n= 240) located in Abu Dhabi city during the study period from March to September 
2009. The random selection was performed by means of sealed envelope technique and was 
accomplished by a third party details. Each 10 pharmacies were represented by one pharmacy, 
based on the geographical location of pharmacies in Abu Dhabi Emirate. Pharmacies included 
in the study were identified from the MoH pharmacy database in the federal
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government located in  Abu Dhabi  capital  and  serving the whole UAE.  The final list of 
selected pharmacies was allocated from the HAAD the regulatory body in Abu Dhabi Emirate. 
5.3.3.3 Sample size 
 
The World Health Organization (WHO) manual [165]  recommended that 600 encounters [20 
facilities and 30 (patients or prescriptions) per facility] were sufficient to reflect the power of 
the study and the statistical inferences. We used a multistage cluster sampling (pharmacies 
represented the cluster and pharmacists represented the population), assuming that there were 
more than one pharmacist in the pharmacy; therefore each pharmacy was represented by one 
pharmacist. This yeilds (n= 24) pharmacists foe the target population. The purpose of the 
study has been explained to the selected consenting pharmacists by a structured information 
sheet. The confidentiality of the information was maintained. (Appendix 6) (Appendix 7) 
5.3.3.4 Data collection 
 
The data included information about the dispensed antibiotics [trade name, generic name, 
strength and duration of treatment]. The study of the pattern of dispensing antibiotics (with 
and/or without prescription) interms of, frequency, costs and indications (reasons for 
dispensing) was permitted via the administration of questionnaire. Pharmacists were asked to 
complete their demographic data and to collect the required data from patients‘ dispensed 
antibiotics (with or without prescriptions). The data was collected during the study period, 
irrespective of completion of the 100 encounters for all transactions dealt, with antibiotics with 
or without prescription. 
V.        The questionnaire 
 
We developed a closed-structured questionnaire (Appendix 8) to examine the influence of 
demographic charateristics (age, gender and years of experience in pharmacy practice) of
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each pharmacist with respect to dispensing antibiotics (with and/or without prescription) in 
terms of legalization, rationality and safety. 
Questionnaire content 
 
Data collection booklet consisted of four sections: 
 
- Pharmacist‘s sociodemographic data (age, gender and years of experience in 
pharmacy practice) 
-    Consumer‘s sociodemographic data (age, gender, socoecomic status) 
 
- Dispensed antibiotic‘s data (trade name, generic name, strength, duration of 
treatment, cost, and mode of dispensing (with or without prescription) 
- The reasons for dispensed antibiotics (the indication for using the antibiotics by 
consumers) 
The financial status of   patients were determined using a scale ranging from low monthly 
income (≤ 2000 Arab Emirates Dirham‘s-AED), medium monthly income (>2000 AED and < 




The questionnaire was administered by the represented pharmacist (n= 24) in each of the 
cluster sample in the 24 pharmacies. Pharmacists were asked to complete their demographic 
data in each section and to fill the required data from the individual consumer (both with and 
without prescription). Each pharmacist was required to fill the data relevant to (n= 100) 
individual pharmacy visitors (consumers).
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5.3.3.5 Statistical analysis 
 
All data were entered, and analyzed by using SPSS version 17. Descriptive statistics were 
generated to determine patterns of antibiotics distribution. Variables found in the univariate 
analysis with significance at the 0.05 or higher (e.g. pharmacist code, age, gender and years of 
experience in pharmacy practice, –consumer   gender and socio-economic status consumer) 
were all strained into a multivariate model. Forward stepwise logistic regression was used 
.Odds ratios (OR), significance, and 95% confidence intervals (95% CI) were calculated to 
predict the related factors of dispensing antibiotics with or without prescription. 
5.3.4    Results 
 
Of the 24 selected pharmacies, only 20 pharmacists completed the questionnaire; at a response 
rate of 80%. Demographic characteristics of the participating pharmacists were shown in 
Table 18.
 






26 30 3 (15%) 
31  40 8 (40%) 
41 51 9 (45%) 
Gender: 
Male 10 (50%) 
Female 10 (50%) 
Years of work experience: 
4 5 2 (10%) 
6 10 4(20%) 
11 20 11(55%) 





















Participating pharmacists  dealt  with  a  total  of  (n=  1645)  patient‘s  transactions  involving 
antibiotics, which were dispensed either with prescriptions [n=1211,  (73.6%)] or without 
prescriptions [n=434, (26.4%)]. Only one pharmacist did not dispense antibiotics without a 
prescription during the study period. Results have shown highly significant associations 
between pharmacists‘ age (p=0.001) and gender (p=0.001) and practice of dispensing 
antibiotics. The male pharmacists had preponderance over the female pharmacists in dealing 
with antibiotics dispensed as OTC. There was an increase in antibiotics dispensed without 
prescriptions associated with the years of pharmacists‗experience in pharmacy practice. 
Over 61.0% of the study population was between 31-50 years of age (patients and consumers). 
Gender and socioeconomic status have significantly affected the manner in acquiring 
antibiotics without a prescription (p=0.012 and p=0.001); respectively. The males and 
participants with low socioeconomic status tend to request antibiotics without a prescription 
more frequently. Patients and consumers demographics were shown in Table 19.
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17 – 28 484 (29.40%) 360 (29.70%) 124 (28.60 % ) 
29 – 40 635 (38.60%) 446 (36.80%) 189 (43.50% ) 
41 – 52 375 (22.80%) 306 (25.30%) 69 (15.90% ) 
> 52 151 (9.20%) 99 (8.20%) 52 (12.00% ) 
Gender 
Male 949 (57.7% ) 717 (59.2% ) 232 (53.5% ) 
Female 696 (42.3% ) 494 (40.8% ) 202 (46.5% ) 
Socio-Economic Status 
High 314 (19.1 % ) 237 (19.6% ) 77 (17.7% ) 
Medium 949 (57.7% ) 768 (63.4% ) 181 (41.7% ) 




*The socio-economic status and the gender of the respondents’ are significantly associated 
 




Logistic-regression model have yielded the following strong predictors for dispensing 
antibiotics without a prescription: pharmacist‘s age (OR= 1.36; p=0.001), pharmacist‘s gender 
(OR 0.621; p=0.001), years of pharmacists‗experience in pharmacy practice (OR 0.686; 
p=0.001), patient‘s socioeconomic (OR 1.836; p=0.001) and patient‘s gender (OR, 1.346; 




Table 20.       Logistic Regression model for factors associated with dispensing and 
 





Variable P value Odd Ratio 95% CI* 
Lower Upper 
Pharmacist age 0.000 1.357 1.178 1.564 
Pharmacist gender 0.000 0.621 0.476 0.811 
Pharmacist experience 0.000 0.686 0.593 0.793 
Patient-customer age 0.515 1.004 0.992 1.016 




0.000 1.836 1.532 2.201 
Reason 0.880 1.002 0.979 1.025 
*CI: Confidence Interval
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The probability of dispensing antibiotics without a prescription increased as the age of 
pharmacists‘ increases too. Furthermore, male consumers with low socioeconomic status 
increased the likelihood of acquiring an antibiotic without a prescription. We did not identify 
any relationship between patient‘s age, reason (diagnosis/symptoms) and acquiring an 




Types of antibiotics used. 
 
Over the study period, 25 types of antibiotics were dispensed with and without a prescription. 
Mann-Whitney U test showed a significant difference between antibiotics dispensed with a 
prescription and those without (p<0.001). Clarithromycin, cefuroxime and 
amoxicillin/clavulanic acid were the most dispensed antibiotics with a prescription (91.5%, 
91.3%, and 66.4%, respectively). Ceftriaxone, amoxicillin and amoxicillin/clavulanic acid 
were the most frequently dispensed antibiotics without a prescription (53.3%, 47.8%, and 
33.6%, respectively). Antibiotics such as ofloxacin, moxifloxacin, cefprozil, cefixime, 
cefidinir and spiramycin were dispensed with prescriptions, while cotrimoxazole and 
spectinomycin were dispensed without a prescription. (Table 21). Antibiotics dispensed with a 
prescription were used for treatment duration of 5, 7 and 10 days, while those dispensed 
without a prescription were used for 3 to 7 days. The treatment duration 
mean of prescribed antibiotics was 6.47 + 2.62 days. The treatment duration mean of 
 
antibiotics dispensed without prescription was 5.74 + 2.484 days. The differences between the 
 
two treatment durations (antibiotics dispensed with prescription and antibiotics dispensed 
without prescription) was statistically significant (p <0.000).  
Each dispensed antibiotics was stratified according to Anatomical Therapeutic Chemical 
Classification (ATC). The trend was expressed by the J01 (third level of ATC system). The total 
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cost for each subgroup is presented in Table 22. The total retail cost of all dispensed antibiotics 
was 152,112 Arab Emirates Dirham‘s AED (41,560 United States Dollars USD. Those dispensed 
with a prescription totaled 122,961 AED (33,595 USD); 80.8% of total cost. Those dispensed 
without prescription totaled 28,151AED (7,691 USD); 19.2% of total cost.  The therapeutic 
subgroup (J01C) was the leading subgroup, with a total cost of 46,435 AED (12,687 USD) on 
prescription antibiotics, and 13,804 AED (3771 USD) on antibiotics dispensed without a 
prescription (29.7%). The macrolide subgroup (J01F) yielded a total cost of 36,088 AED (9,860 
USD) 
 


































% No. of transaction % 
1 Amoxicillin/clavula
nic acid 
J01CR02 402 267 66.4% 135 33.6% 1 
2 Clarithromycin J01FA09 235 214 91.1% 21 8.9% 2 
3 Amoxicillin J01CA04 212 99 46.7% 113 53.3% 3 
4 Cefuroxime J01DC02 183 167 91.3% 16 8.7% 4 
5 Ciprofloxacin J01MA02 140 110 78.6% 30 21.4% 5 
6 Azithromycin J01FA10 109 79 72.5% 30 27.5% 6 
7 Ceftriaxone J01DD04 69 36 52.2% 33 47.8% 7 
8 Moxifloxacin J01MA14 53 53 100% 0 0% 8 
9 Cefdinir J01DD15 35 35 100% 0 0% 9 
10 Cefixime J01DD08 27 27 100% 0 0% 10 
11 Ampicillin J01CA01 25 13 52% 12 48% 11 
12 Cefpodoxime J01DD13 22 17 77.3% 5 22.7% 12 
13 Levofloxacin J01MA12 21 16 76.2% 5 23.8% 13 
14 Metronidazole P01AB01 19 6 31.6% 13 68.4% 14 
15 Metronidazole P01AB01 19 6 31.6% 13 68.4% 14 
16 Metronidazole J01XD01 16 12 75% 4 25% 15 
17 Norfloxacin J01MA06 16 14 87.5% 2 12.5 15 
18 Clindamycin J01FF01 14 11 78.6% 3 21.4% 16 
19 Ofloxacin J01MA01 6 6 100% 0 0% 17 
20 Spiramycine J01FA02 5 5 100% 0 0% 18 
21 Co-trimoxazole J01EE01 5 0 0% 5 100% 18 
22 Erythromycin J01FA01 4 1 25% 3 75% 19 
23 Cefprozil J01DC10 4 4 100% 0 0% 19 
24 Clotrimazole G01AF02 3 3 100% 0 0% 20 
25 Spectinomycin J01XX04 1 0 0% 1 100% 21 



















Table 22.           Distribution of J01 Antibiotic and cost 
 
 
ATC Name of 
therapeutic subgroup 
Cost Total cost 
With prescription Without prescription  
J01A Tetracyclines 1002 205 1207 
J01C Penicillins 32631 13804 46435 
J01D Other beta-lactam 
antibacterials 
36786 5504 42290 
J01F Macrolides 31634 4454 36088 
J01M Quinolones 20616 4904 25520 
J01E Sulphonamides & 
Trimethoprime 
0 205 205 
J01X Other 292 75 367 
Total  122961 29151 152112 
 
*Cost in Arab Emirates Dirham, 1$ = 3.67 AED
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Reasons for prescribing and dispensing antibiotics 
 
The study results revealed that the most prescribed and OTC dispensed antibiotic was Co- 
amoxiclav for several reasons (Table 23.). Amoxicillin/clavulanic acid was prescribed for 
sore throat where as it was dispensed more as an OTC this is also the case with amoxicillin. 
Coamoxiclav was preferred over cefuroxime and clarithromycin, while azithromycin was 
more likely to be chosen  by the  pharmacists.  The results indicated that coamoxiclav and 
cefuroxime were frequently prescribed for cough, whereas amoxicillin and 
Amoxicillin/clavulanic acid were favoured as OTC. Amoxicillin/clavulanic acid and 
clarithromycin were prescribed as well as dispensed as OTC for common cold. 
Amoxicillin/clavulanic acid, cefuroxime, clarithromycin, and azithromycinwe the most 
prescribed antibiotics for upper respiratory tract infection, whereas amoxicillin, 
amoxicillin/clavulanic acid and azithromycin were dispensed as OTC. Cefixime and 
Moxifloxacin were not dispensed as OTC, but were always dispensed with prescription for 
upper and lower respiratory tract infections. Results revealed that Ceftriaxone was similarly 
prescribed by doctors and dispensed without prescription for sexually transmitted diseases 
(STD). Ciprofloxacin was the most widely prescribed antibiotic for urinary tract infections. 
Amoxicillin and macrolides (clarithromycin and azithromycin) were usually prescribed and 
dispensed as OTC for infection with Helicobacter. Pylori. Dentists and pharmacists have both 
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5.3.6    Discussions 
 
In the current study we assessed pharmacist‘s socio demographic profile in terms of their age, 
gender and years of work experience with regard to dispensing antibiotics with or without 
prescription. This was conducted through a closed-structured questionnaire. This has 
contributed to the relatively high response rate of the selected sample of pharmacies (80%) as 
compared to (98.8%) rate which have been reported from Spain [166] and 37.7% reported 
previously in the UAE [167]. The gender of participating pharmacists was equally distributed, 
when compared to the gender of participants in a Pakistani study [168] in which they were 
predominantly males (99%). 
The results revealed a significant association between the pharmacist‘s age and the rate of 
dispensing antibiotics without a prescription (p=0.001).  Also In addition, 95% of the 
pharmacists in the study dispensed antibiotics without a prescription, which has exceeded the 
85% rate reported in Brazil [169]. During the study period a total of 1645 transactions involving 
 
antibiotics were reported; 73.6% with a prescription from a physician or dentist and 26.4% 
without a prescription. The reported results were better than those reported in Jordan (42.5%), 
Nigeria (57.7%), Mongolia (57.9%), and Palestine (60%), respectively.  [170, 171, 172, 173] 
The males within the consumers cohort, (57.7%) were and more likely to acquire antibiotic 
 
without a prescription, especially, those with a low socioeconomic status. 
 
The logistic regression model results have indicated that the risk factors associated with 
antibiotics dispensed without prescription were pharmacist‘s age, gender and years of work 
experience, as well as patient socioeconomic status and gender. Similar findings have been 
reported in Spain [166], Jordan [145] and Brazil. [174]
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Regarding specific antibiotics, results have revealed that, the top ten dispensed antibiotics in 
descending order were amoxicillin/clavulanic acid, clarithromycin, amoxicillin, cefuroxime, 
ciprofloxacin, azithromycin, ceftriaxone, moxifloxacin, cefdinir and cefixime,. This pattern 
was similar to that reported from Croatia, [175] yet differs from those reported in Indonesia [176] 
where widely- restricted amphenicols (chloramphenicol group) are still in use despite their 
harmful aplastic anemia side effect. Healthcare providers continue prescribing antibiotics for 
respiratory infections, which were most likely viral in origin. Such a prescription pattern will 
likely contribute to the emergence and spread of resistance. [177, 178] 
The most common reason for both dispensing antibiotics with prescription and dispensing 
 
antibiotics without a prescription was upper respiratory tract infections.  These infections were 
mostly non-specific type in which sinus, pharyngeal and lower airways symptoms were 
frequently presented but no compelling evidence for bacterial infection. It has been reported 
that pharmacists can have the same behavior of physicians in prescribing broad spectrum 
antibiotics [179] due to their experience to perform quick and simple examination on the patient 




Another reason for this behavior may be due to the persistent requests from patients from the 
pharmacist to dispense antibiotics to them without a prescription according to their previous 




Although the major cause of urinary tract infection was Escherichia coli, which was resistant 
to quinolones and fluoroquinolones, [180, 181] the current study results revealed that both 
prescribers and dispensing pharmacists were still recommending them. Furthermore, no
  96  
 
patient in the studied population was treated by the drug of choice, nitrofurantoin, which was a 
compelling indication for the infection by this pathogen. [182] 
Prevalence of dispensing antibiotics without a prescription in Abu Dhabi has declined since 
the implementation of a mandatory medical insurance program by HAAD. This decline has 
reached 68.4% in 2005. [167, 15] 
Our data showed a further decline of 26.4%, nearly half the rate reported in 2006. This can be 
 
attributed to the insurance mandate, since patients must now acquire a prescription for the 
needed antibiotic.  The enforcement of the mandate requires that the offending pharmacist will 
be suspended from practice for 30 days, therefore; few pharmacists were dispensing 
antibiotics without prescriptions. Furthermore, HAAD is now a member of The Alliance for 
the Prudent Use of Antibiotics (APUA). HAAD is organizing workshops on antibiotics 
overuse, antibiotics resistance and a campaign to raise the adherence of pharmacists to the 
antibiotics mandate. 
The study findings revealed that, there was a lack of antibiotic usage guidelines, which was 
anticipated to lead to antibiotics misuse and over-prescribing, as in accordance with other 
similar studies. [166, 167, 174] 




Controlling the use of antibiotics is of paramount importance in both the community and 
hospital settings. The first step to overcome this is by identifying the prescribing, dispensing 
and consumption of the antibiotics used in the community. [184]
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Therefore, we believe that in order to combat the problem of OTC dispensing of antibiotics, it 
is necessary to enhance pharmacists and patients awareness, perform random surveillance and 





5.3.7 Limitation of the study 
 
We have utilized self-administrated questionnaire by participating pharmacists to collect data; 
however, this method of data collection may experienced the following Limitations: 1) it may 
raise some discrepancies within the participating pharmacists with different work load 2) it 






Prevalence of dispensing antibiotics by community pharmacists without prescription is illegal 
and alarming. Pharmacists with long pharmacy practice dispense antibiotics as OTC more 
often than younger ones. Pharmacists and patients‘ perception, knowledge and attitude are 
crucial in developing interventions to improve the current practices of dispensing antibiotics. 
Insurance company may develop low-priced formulary antibiotics models to help low income 
patients to acquire their antibiotics after consulting the physicians. It‘s recommended to avail
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antibiotics, such as Nitrofurantion for UTIs as an alternative to the Quinolones in order to 
reduce resistance to Ciprofloxacin also drug utilization research have become critical, in order 
to gain firsthand knowledge of what is being consumed.  In the absence of this research, and 
subsequent guidelines, protocols and policies, it would not be possible to identify the problems 
and set priorities to improve and change current practice. Further research and patient 
interviews will provide greater insight into the problem.






Charles University in Prague,    Faculty of Pharmacy in Hradec Kralove 
Department:  Department of Social and Clinical Pharmacy          
Candidate   PharmDr. Abobakr  Abasaeed Elhag 
Supervisor   :  prof. RNDr. Jiri Vlcek, CSc.      
Title of Doctoral Thesis: Analysis of the Use of Antibiotics in the United Arab 
Emirates 
 Introduction and Aims: 
The misuse of antibiotics for viral infections (for which they are of no value) and the 
immoderate use of broad spectrum antibiotics instead of narrower spectrum antibiotics have 
been well-documented and reported. Therefore the inappropriate use of antibiotics is getting a 
global problem, mainly in the developing countries. Emergence of antibiotics resistance is often 
a result of irrational prescribing patterns, misuse of the antibiotics as well as self-medication. 
Although the United Arab Emirates (UAE]) antimicrobial policy restricts dispensing of 
antibiotics without prescription , studies revealed the wide availability of these agents over the 
counter (OTC), their over prescribing pattern and the high prevalence of self-medication with 
antibiotics, unfortunately and regardless of this results, there is a lack and paucity in studies that 
tracking the prevalence of antibiotics resistance. The aim of our research was to evaluate the 
attitude of the community towards the use of antibiotics, estimate the prevalence of self-
medication with them, identify the socio-demographic factors, which are related to the 
community and the pharmacists, that affecting this practice .In our research we also identify the 
frequent used antibiotics, their sources of obtaining and the reasons why they used.  
1. Attitudes towards antibiotics use among banking employees in Sudan, Oman and UAE. 
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Aims:  
The aim was to assess current knowledge, attitudes and behaviour towards antibiotics (ATB) 
among banking employees, evaluate parents‘ awareness of antibiotics use by their children and 
determine sources of antibiotics use.  
Methodology: 
A descriptive-cross sectional study was conducted in Sudan, Oman and UAE, targeted banking 
employees. A 18-item questionnaire was used for data collection. Descriptive statistical analysis 
was done in SPSS® version 11 software.  
Results: 
450 employees were nominated (150 each region), only 331 employees participated in the study; 
the rate of response was 64.6%, 74.0%, 82.0% in Sudan, Oman and UAE respectively. Mean 
age was 34 years. Males represented 66.6%.Within the participants 49.3%, 26.9%, and 47.8% 
were reported antibiotics use without prescription in Sudan, Oman and UAE respectively. 
Parents with higher educational level were tending to give their children antibiotics without 
prescription mainly in Sudan.  Amoxicillin and amoxicillin / clavulanic acid were the leading 
used antibiotics by respondents and their children mainly for respiratory tract infections. 53.1% 
obtained antibiotics as over the counter based on their own request for the specific antibiotic. 
Conclusion:  
Self-medication with antibiotics is reasonably high within banking employees in Sudan, Oman 
and UAE. Multi factorial interventions are believed to reduce the incidence of this practice 
including: an intensive public health plans; awareness regarding the consequences of self-
medication with antibiotics throughout health education and restrictions that stop the availability 
of antibiotics without prescription. 
2- Self-medication with antibiotics by the community of Abu Dhabi Emirate, United Arab 




The study aimed at identifying the major socio-economic factors that are related to self-
medication with antibiotics and the main types of antibiotics used in this practice and reasons 
behind it. Another goal was to characterize the sources of obtaining antibiotics without 
prescription.  
Methodology:  
A Descriptive-cross sectional study was conducted during Abu Dhabi Book Fair; in April 
2006. Visitors of the Book Fair were invited to participate in the study.  Data were collected   
through  a  structured,   pretested,   validated,   self   administrative questionnaire. In order to 
help the participants to remember the antibiotics they used, we developed a portrait containing 
labels from the available types of antibiotics in the health premises.  
Data obtained was entered into a micro computer running the statistical package for social 
sciences (SPSS version 11.0) software. P value was calculated by setting the reference value 
and comparing it with other values. P < 0.05 was considered statistically significant. 
Results:  
Out of 1000 invited visitors 860 agreed to participate in the study; the rate of response was 
86.0%. Males represented 65.8% of the participants. Use of antibiotics was significantly 
affected by age p < 0.001 as well as the educational level p=0.023. Amoxicillin was the 
antibiotic most commonly used by the participants and for their children (46.3% and 70%‘ 
respectively). 44.3% acquired their antibiotics without a prescription as self-medication. The 
method of obtaining antibiotics was significantly affected by the age of the participants  
p= 0.014. There  were  45.6%  out  all  participants  stated  that,  they can  intentionally  use 
antibiotics as self-medication without a medical consultation, which was significantly affected 
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by the educational  level  of the visitors  p < 0.001.  A significant association was found 
between the behavior of keeping antibiotics at home and the gender  
P < 0.001 and age p=0.002.  Influenza had been the major reason that mostly treated by 
prescribed or self -medication antibiotics. This finding confirms the belief of the community 
that antibiotics can treat and eradicate any infection irrespective of their origin. 
Conclusion:  
The study confirmed that antibiotic self-medication is a relatively frequent problem in UAE.  
Interventions at different levels are required in order to reduce the frequency of antibiotics 
misuse. Managerial interventions: involve work on up-dating the antibiotics policy and guide 
to antimicrobial therapy 2nd Edition 1998, establish a National Antibiotic therapeutic adviser 
committee. The educational interventions for both prescribers and patients/consumers 
(educational campaigns on antibiotics, their uses and limitations) are of paramount 
importance. Moreover, the National mandatory health insurance scheme may play an 
important role to diminish this problem.
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3- A comparative study between prescribed and over –the-counter antibiotics 
Aims: 
The main aims of this study were to examine the influence of demographic characteristics (age, 
gender and years of work experience) of the pharmacist with respect to dispensing antibiotics 
(with and / or without prescription) in terms of legalization, rationality and safety and to 
examine the pattern of dispensing antibiotics (with and / or without prescription) in terms of 
frequency, costs and indications (reasons for dispensing). 
Methodology:  
Cross-sectional study, conducted in Abu Dhabi Emirate during the period from March to 
September 2009. The study carried out in (n= 24) randomly selected community pharmacies. 
Data were collected through closed-structured questionnaire. The cost was calculated in 
Emirate Dirham, each dirham is equivalent to 3.7 US$ . Data were entered and analyzed using 
SSPS version 17. Descriptive Statistics: odds ratios (OR), significance and 95% CI were 
calculated and logistic regression was conducted. 
Results:  
Participating pharmacists conducted a total of 1645 transactions involving antibiotics, 1211 
(73.6%) dispensed with prescriptions and 434 (26.4%) without prescriptions. Strong predictors 
for dispensing antibiotics without a prescription using the logistic-regression model were 
pharmacist‘s age ([OR] 1.36; P=.001), pharmacist‘s gender (OR 0.621; P=.001), experience 
(OR 0.686; P=.001), and patient‘s socioeconomic (OR 1.836; P=.001) patient‘s gender (OR, 
1.346; P=.012)  Clarithromycin, cefuroxime and amoxicillin/clavulanic acid were the most 
frequently dispensed antibiotics with a prescription (91.5%, 91.3%, and 66.4%, respectively). 
Ceftriaxone, amoxicillin and amoxicillin/clavulanic acid were the most frequently dispensed 
antibiotics without a prescription (53.3%, 47.8%, and 33.6% respectively). Antibiotics 
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dispensed with a prescription were frequently given as a 5-, 7- or 10-day regimen, while those 
dispensed without a prescription were frequently given for duration of 3 to 7 days. Co-
amoxiclav was commonly dispensed for sore throat without a prescription. Ceftriaxone was 
dispensed at a similar rate, both with and without a prescription for sexually transmitted 
diseases (STD).  
Conclusion:  
Prevalence of dispensing antibiotics by community pharmacists without prescription is illegal 
and alarming. Pharmacists with long pharmacy practice dispense antibiotics as OTC more often 
than younger ones. Pharmacists and patients‘ perception, knowledge and attitude are crucial in 
developing interventions to improve the current practices of dispensing antibiotics. Insurance 
company may develop low-priced formulary antibiotics models to help low income patients to 
acquire their antibiotics after consulting the physicians. Drug utilization research have become 
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Název disertační práce: Analýza používání antibiotik ve Spojených arabských emirátech. 
 Úvod a cíl: 
Zneužívání protiinfekčních léčiv pro léčbu virových infekcí a masivní preference 
širokospektrých antibiotik před úzko-spektrými je dobře dokumentována a publikována. Proto 
nevhodné užití antibiotik se stává globálním problémem, především v rozvojových zemích. 
Antibiotická rezistence může vznikat i v důsledku neracionálního užití léčiv, zneužívání 
antibiotik stejně jako samoléčení antibiotiky. 
Ačkoli Spojené Arabské Emiráty (UAE) zakazují výdej antibiotik bez předpisu, studie ukazují 
snadnou dostupnost těchto léčiv k samoléčení a rozsáhlé zkušenosti se samoléčením v regionu a 
při tom nejsou zde dostupné informace o vývoje rezistence. Cílem naší studie bylo popsat vztah 
populace k užívání antibiotik, určit prevalenci samoléčby a identifikovat sociodemografické 
faktory, které charakterizují populaci či lékárníky pozitivně nakloněných k samoléčbě 
antibiotiky. V naší studii bylo prvním cílem sledovat jaká antibiotika jsou nejčastěji k samoléčbě 
využívána, jaký byl jejich zdroj a důvod k použití. Práce měla následující projekty: 
1. Analýza používání antibiotik mezi bankovními úředníky Sudánu, Ománu a UAE 
Cíle:  
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Analyzovat současné znalosti, postoje a chování k antibiotikům (ATB) mezi bankovními 
úředníky a určit zdroje  antibiotické spotřeby  
Metodika: 
Deskriptivní průřezová studie byla provedena v Sudanu, Omanu a nebo UAE na populaci 
bankovních úředníků. Byl použit 18-ti položkový dotazník. Deskriptivní analýza byla provedena 
pomocí statistického software SPSS® verze 11.  
Výsledky: 
450 respondentů bylo požádáno o účast ve výzkumu  (z každé země 150).  331 souhlasilo s svou 
účastí ve studii a proto návratnost byla  64.6% v Súdánu, 74.0% v Ománu a 82.0% v UAE. 
Průměrný věk respondentů byl 34 let. Většinu souboru tvořili muži (66.6%). V Súdánu užívalo 
antibiotika 49.3%, v Ománu 26.9%, a v UAE 47.8% respondentů. Především v Súdánu měli 
rodiče s vyšším vzděláním tendenci častěji užívat antibiotika k samoléčbě svých dětí.  
Amoxicillin a potenciální amoxicillin byly preferenčními přípravky používaných při samoléčení 
jak respondenty tak i jejich dětí. Antibiotika byla nejčastěji používána pro léčbu respiračních 
nemocí.  53.1% respondentů požadovalo v lékárně konkrétní antibiotikum a ne radu jak léčit 
jejich potíže. 
Závěr:  
Samoléčba antibiotiky je vysoká mezi bankovními úřadníky všech tří zemí – Súdánu, Ománu a 
UAE. K redukci této praxe je nutné hledat komplexní řešení včetně intenzivní zdravotní politiky, 
vymezení role samoléčení a zdůrazňování jejich rizik a restriktivní opatření s cílem snížit 
dostupnost antibiotik bez předpisu. 
2- Samoléčba antibiotiky u občanů emirátu Abu Dhabi Spojených arabských emirátů  (UAE) 
Cíle:  
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Cílem studie je identifikovat základní socio-ekonomické faktory ovlivňující samoléčbu 
antibiotiky a identifikovat která antibiotika jsou takto používána a proč. 
Jiným cílem je charakterizovat zdroje, kde lze získat antibiotika bez předpisu  
Metodologie:  
Deskritivní průřezová studie byla realizována mezi účastníky knižního veletrhu v Abu Dhabi v 
dubnu 2006. Data byla získána strukturovaným, validovaným dotazníkem, který respondent 
vyplnili sami. Pro připomeutí jména přípravku byl vyroben náhled balení jednotlivých 
dostupných antibiotik.  
Data byla hodnocena pomocí statistického software SPSS (verze 11.0).  
Výsledky:  
860 z 1000 oslovených návštěvníků souhlasilo s účastí ve studii (návratnost je  86.0%). Muži 
reprezentovali 65.8% respondentů. Používání antibiotik signifikantně ovlivnil věk (p < 0.001) 
a stupeň dosaženého vzdělání (p=0.023). Respondenti (46,3%) a jejich děti (70%) nejčastěji 
byli exponováni amoxicilinem. 44.3% respondentů používalo antibiotika k samoléčbě. Věk byl 
významným prediktorem jak respondent antibiotika získal (p= 0.014). 45.6% všech 
respondentů jsou ochotni užít antibiotika bez lékařského doporučení a i to je ovlivněno věkem 
respondentů (p < 0.001).  Byl nalezen signifikantní vztah mezi respondenty, mající antibiotika 
doma a jejich pohlavím (p < 0.001) a věkem (p=0.002).  Nejčastěji respondenti užívali 
samoléčbu antibiotiky při chřipce. Nálezy podporují hypotézu, že laická veřejnost věří, že 
antibiotika mohou léčit a eradikovat všechny infekce bez ohledu na jejich původce. 
Závěr:  
Studie ukazuje, že samoléčba antibiotiky je relativně častý problém v UAE.  Intervence na 
různých úrovních je nutná k omezení zneužívání antibiotik. Manažerská intervence by měla 
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zahrnout aktualizaci antibiotické politiky ale i průvodce antimikrobiální terapií (nyní je 
dostupné jen druhé vydání z roku 1998) a založit národní komisi zabývající se terapií antibiotik. 
Edukační opatření pro lékaře a pacienty/uživatele (např. edukační kampaň týkající se použití a 
limitace antibiotik) mají velkou významnost. Navíc – národní systém zdravotního pojištění 
může hrát důležitou roli ve snižování problémů týkající se používání antibiotik 
3- Srovnávací studie mezi antibiotiky na předpis a získanými v lékárně přímým prodejem 
 
Cíle: 
Hlavním cílem této studie bylo sledovat vliv některých charakteristik lékárníků (věk, pohlaví a 
délky praxe) na způsob dispenzace antibiotik (při výdeji na předpis nebo pro samoléčení) 
týkající se právních aspektů a racionality včetně bezpečnosti a analyzovat preferenci 
vydávaných antibiotik z pohledu  nákladů a indikací (důvod použití antibiotik při výdeji). 
Metodologie:  
Průřezová studie provedená v Emirátu Abu Dhabi v období benzen až září 2009. Studie 
proběhla ve 24 náhodně vybraných veřejných lékárnách.  Data byla sbírána strukturovaným 
dotazníkem s uzavřenými otázkami. Pro klasifikaci antibiotik byl použit ATC/DDD systém. 
Náklady byly vyjádřeny ve finančních jednotkách UAE – Dirham (cca 3.7 US$). Data byla 
analyzována pomocí statistického software SSPS verze 17. Vztahy byl vyjádřen pomocí 
poměru šancí (OR) a  95% konfidenčního intervalu a byla provedena logistická regresní 
analýza. 
Výsledky:  
Participující farmaceuti provedly 1645 transakcí s antibiotiky, 1211 (73.6%) dispensovali na 
základě lékařského předpisu a 434 (26.4%) bez předpisu. Dle logistické regrese byl silným 
prediktorem vydání antibiotik bez receptu: věk ([OR] 1.36; P=.001), pohlaví (0.621; P=.001) a 
profesní zkušenost (OR 0.686; P=.001) farmaceuta a socioekonomický stav (OR 1.836; 
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P=.001) a pohlaví (OR, 1.346; P=.012) pacienta. Klaritromycin (91,5%), cefuroxim (91,3%) a 
potenciální amoxicillin (66,4%)) byly nejčastěji vydávaná antibiotika na předpis. Ceftriaxone 
(53,3%), amoxicillin (47,8%) a potenciální amoxicillin byly nejčastěji vydány bez lékařského 
předpisu. Antibiotika předepsaná byla doporučena nejčastěji pro 5, 7 nebo 10denní léčebnou 
kůru, zatímco antibiotika vydaná bez předpisu byla vydána na 3 – 7 dní. Koamoxiclav byl 
nejčastěji vydáván k samoléčení na bolesti v krku. Ceftriaxone byl se stejnou frekvencí vydán 
bez předpisu a předepisován na pohlavně přenášené choroby. 
Závěr:  
Vysoká prevalence dispenzace antibiotik ve veřejných lékárnách je nezákonná a alarmující. 
Farmaceuti s dlouhou praxí prodávají antibiotika bez lékařského předpisu mnohem častěji než 
jejich mladší kolegové. Zdravotní pojišťovna by měla po konzultaci s lékaři vyvinout seznam 
nízkonákladových antibiotik, aby protiinfekční léčba byla dostupná pro nízko-příjmové 
skupiny. Analýza spotřeby antibiotik je však na začátku zásadní, aby bylo známo, jaké priority 














To bring about the necessary changes in prescribers' and pharmacists‘ behavior, there is a need 
to increase the awareness of health professionals by adequate information and training during 
professional education and in-post training. 
 
Pharmacists with practice experience of more than 20 years were found to have higher 
 
tendency of OTC dispensing. This can most properly be attributed to the lack of subjects that 
 
are related to the rational use of medicines in the curricula during the two last decades of the 
 
twentieth century in universities and pharmacy institutes. Thus we are emphasizing and highly 
 
recommending the inclusion of such subjects in the curricula. 
 
Authorities should update the antibiotic policy to include penalties and punishments against 
those who dispense antibiotics without prescription to diminish this practice, speed up the 
implementation of the national medical insurance scheme which will protect and help the low 
income people from the irrational use of antibiotics by enabling and facilitating the 
consultation of a prescriber in case of suffering from any illness. In addition, it‘s also 
recommended to avail antibiotics, such as Nitrofurantion for UTIs as an alternative to the 
Quinolones in order to avoid and reduce the suspected resistance to them. 
Support of research will be essential for tackling the problem of the improper prescribing, 
dispensing and the mode of spread of antimicrobial resistance.  
Information measures through national educational campaigns along with simplified 
awareness newsletters and bulletins dedicated for the general public showing the different 
types of infections and their causing organisms and whether antibiotics are effective or not ,
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should be conducted and distributed. This should mainly focus on highly educated segments of 
the society and those with low socio-economic status. This will help in changing the common 
concept that influenza can be treated with the use of antibiotics. 
 
Patients‘ concepts  should  be corrected and their awareness  should be  raised  to  the  fact that 
  
avoiding  physicians‘ visits  will  not  save  their  money  but  on  the  contrary  it would make them 
 
more vulnerable to be dispensed medicines that are inappropriate and ineffective for their 
 
complains and this is could be due to incorrect diagnosis or incomplete treatment. Eventually 
 
they will be in need of new medications which results in higher costs.
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12.1 Appendix 1: Use of antibiotics questionnaire 
 
 
Study on the use of antibiotics 
 








2-   Your gender: 
 Male 
 Female 
3-   please indicate your educational level : 
 Primary education 
 Secondary education 
 Secondary Vocational 
 University graduate 
 Post graduate 
 
4-  Do you have children below 16 years? 
 Yes (If yes, please continue to part B of the questionnaire after answering part A) 
 No 

     The Questionnaire 
A. Participant’s antibiotic use. 
1- Have you taken any antibiotics in the last 12 months? 

























5- How did you obtain them? 
   With prescription (Prescribed by a doctor or dentist or hospital ) 
   Without prescription 
   Leftovers from previous prescription available at home 
   From antibiotics intended from a relative or friend 
   Other sources. 
 
Please elaborate   ------------------------------------------------------------------------------------------- 
6- In general would you use antibiotics for yourself without contacting your doctor/ dentist 
/hospital? 
   Yes (if yes, continue to question 7) 




7- What would be the reasons or symptoms for antibiotic use without contacting the doctor? 
   Runny nose 
   Cough 
   Bronchitis 
   Sore throat 
   Sinusitis 
   Fever 
   Flue 
   Ear infections 
   Toothache 
   Diarrhoea 
   Urinary tract infections
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   Other infections/diseases 
 






B. The use of antibiotics for your children who are under 16 
8- Have you use any antibiotics for any of your children below 16 years in the last 12 months: 
































12- How did you obtain the antibiotics for them? 
   With prescription (Prescribed by a doctor or dentist or hospital ) 
   Without prescription 
   Leftovers from previous prescription available at home 
   From antibiotics intended from a relative or friend 
   Other sources. 
 
Please elaborate   -------------------------------------------------------------------------------------------
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13- In general would you use antibiotics for your children below 16 without contacting your 
doctor/dentist/hospital? 
   Yes (if yes, continue to question 14) 




14- What would be the reasons or symptoms for antibiotic use for your children without 
contacting the doctor/dentist? 
   Runny nose 
   Cough 
   Bronchitis 
   Sore throat 
   Sinusitis 
   Fever 
   Flue 
   Ear infections 
   Toothache 
   Diarrhoea 
   Urinary tract infections 
   Other infections/diseases 
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(1- Benzyl Penicillin                                                                       2- Procaine Peniciilin 
 
3- Amoxycillin ( Penamox , Amoxil , Amoxydar )                         4- Ampicillin ( Penberitin) 
 
5- Ampiclox  (Amoclan , Klavox , Amoxiclav)                                6- Amoxicillin/clavulanic acid  
, Julmentin , 
 
7- Benthazine Penicillin ( Penadur , Retarpen )                          8- Cephacor ( Ceclor) 
 
9- Cefixime ( Suprax , Magnacef )                                                10- Cephalexin  (Kefflex) 
 
11- Cephtazidime ( Fortum )                                                          12- Ceftriaxone( Rocephin) 
 
13-Cefuroxime ( Zinacef , Zinnat , , Maxil , Cefuzime )                 14- Tetracycline 
 
15- Doxycycline ( Zadorin , Doxydar)                                            16- Gentamycin(Gentadar) 
 
17- Erythromycin Erythrodar. Erythrocin)                                     18- Amikacin 
 
19- Azithromycin ( Zithromax)                                                       20-Clarithromycin ( Kalcid) 
 
21- Co-trimoxazole  ( Septrin , Bactrim , Balkatrim )                     22- Ofloxacin ( Tarivid) 
 
23- Spectinomycin (togamycin) 
 
24- Ciprofloxacin ( Ciprobay ,  Ciprodar , Sarf , Ciplox  ) 
 





































































































You are being invited to take part in a research study. Before you decide it is important for 
you to understand why the research is being done and what it will involve. Please take time to 
read the following information carefully. Ask us if there is anything that is not clear or if you 
would like more information. Take time to decide whether or not you wish to take part. 
This study will examine the antibiotic prescribing pattern in the pharmacy. The results of the 
research may be published. You will not be identified in any report/publication. You will be 
given a copy of the information sheet and a signed consent to keep. 
We wish to thank you for taking part in the study. 
 
Thanking you in taking the time and reading this information sheet. 
 
For further information please contact: 
Dr. Abobakr Abasaeed 
Abu Dhabi -UAE. Tel: (+971) 50 73 76 987
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I have read the patient information sheet (or have had it read to me) and I understand the 





I understand that if, at any stage, I do not wish to participate any further in the study I can 
withdraw. I do not have to explain why and I know that it will not affect my future care or 
cause any displeasure. 













Date                                                                                         Pharmacy Code
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12.8 Appendix 8: Questionnaire of Study III 
 
 






2- Pharmacy Number……………………. 
 
Pharmacist demography 
3-  Age: 




1- Male                             2- female
 




6-  Age: 




1- Male                                    2- Female
8-  Socio- Economic Status: 
 




9-  Trade Name:------------------------------- 














Way of Dispensing 
 
14- Prescription: 
1- Yes                2-No 
 
Reasons for Dispensing 
15- Tick from the list the reasons ( Max 3 reasons ) 
 
1- Sore Throat  9- Diarrhea 
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